News

View

Sort By

Mar 26, 2020

Prevail Therapeutics Reports Full Year 2019 Financial Results and Business Highlights

Mar 25, 2020

BELLUS Health Announces Closing of Transaction to Acquire Remaining Intellectual Property Rights to BLU-5937 from adMare BioInnovations

Mar 25, 2020

Alector Enters into a Licensing Agreement with Innovent Biologics to Develop and Commercialize AL008 in Oncology Indications in China

Mar 25, 2020

89bio Appoints Healthcare Industry Veteran Steven Altschuler, M.D., as Chairman of the Board of Directors

Mar 24, 2020

scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2019 Financial Results and Provides Business Update

Mar 24, 2020

Prevail Therapeutics Receives U.S. FDA Fast Track Designation for PR006 to Slow the Progression of Frontotemporal Dementia with a GRN Mutation

Mar 24, 2020

Alector Reports 2019 Fourth Quarter and Full Year Financial Results and Business Highlights

Mar 24, 2020

Glaukos Provides COVID-19 Pandemic Update

Mar 23, 2020

Alector Announces the Appointment of Paula Hammond, Ph.D., to the Board of Directors

Mar 23, 2020

ObsEva Provides Update Related to COVID-19 Pandemic

Mar 23, 2020

Kimberly Lathroum Joins Arcutis as Vice President of Marketing

Mar 23, 2020

Fusion Pharmaceuticals Appoints James J. O’Leary, M.D. As Chief Medical Officer

Mar 20, 2020

Verona Pharma plc: Issue of Equity and Total Voting Rights

Mar 19, 2020

BELLUS Health Announces Completion of Enrollment in Phase 2 RELIEF Trial of BLU-5937 for the Treatment of Refractory Chronic Cough

Mar 18, 2020

SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Nirogacestat, Extending Patent Protection into 2039

Mar 18, 2020

Alpine Immune Sciences’ ALPN-101 Receives FDA Orphan Drug Designations for the Prevention and Treatment of Acute Graft Versus Host Disease

Mar 18, 2020

89bio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Mar 16, 2020

TURNING POINT THERAPEUTICS REPORTS FOURTH-QUARTER, FULL- YEAR 2019 FINANCIAL AND OPERATIONAL RESULTS

Mar 16, 2020

Arcutis Announces Inclusion of Children in On-going Pivotal Phase 3 Clinical Trials Evaluating Topical Roflumilast (ARQ-151) as a Potential Once Daily Topical Treatment for Plaque Psoriasis

Mar 16, 2020

Aerpio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

Mar 16, 2020

Arvinas Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Mar 13, 2020

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results

Mar 12, 2020

HARPOON THERAPEUTICS REPORTS FOURTH QUARTER 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 12, 2020

Nabriva Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results and Recent Corporate Highlights

Mar 12, 2020

Selecta Biosciences Reports Fourth Quarter 2019 and Year-End Financial Results

Mar 12, 2020

resTORbio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Mar 12, 2020

X4 Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results

Mar 12, 2020

Sonendo® Appoints Amit Agarwal as Vice President of Marketing

Mar 12, 2020

Synlogic Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

Mar 12, 2020

SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights

Mar 12, 2020

CTI BioPharma Reports Fourth Quarter and Full Year 2019 Financial Results

Mar 11, 2020

Silverback Therapeutics Raises $78.5 Million in Oversubscribed Series B Financing

Mar 11, 2020

Verrica Pharmaceuticals Secures $55 Million in Loan Facilities Led by Silicon Valley Bank

Mar 10, 2020

KALA PHARMACEUTICALS ANNOUNCES PRICING OF PUBLIC OFFERING OF 16,000,000 SHARES OF COMMON STOCK

Mar 9, 2020

Tricida Hires Robert McKague as Executive Vice President, General Counsel & Chief Compliance Officer

Mar 9, 2020

CRINETICS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 9, 2020

KALA PHARMACEUTICALS ANNOUNCES STATISTICALLY SIGNIFICANT RESULTS FOR PRIMARY AND KEY SECONDARY ENDPOINTS IN STRIDE 3 CLINICAL TRIAL EVALUATING EYSUVIS™ FOR SIGNS AND SYMPTOMS OF DRY EYE DISEASE

Mar 9, 2020

Xenon Pharmaceuticals Reports 2019 Financial Results and Provides Corporate Update

Mar 9, 2020

NeuroPace RNS System Receives FDA Approval for MRI Labeling, Allowing Thousands More Patients to Benefit from Personalized, Data-Driven Epilepsy Treatment

Mar 6, 2020

Keros Therapeutics Closes $56 Million Series C Financing to Advance its Programs in Hematologic and Musculoskeletal Disorders

Mar 6, 2020

CTI BioPharma Announces Closing of Rights Offering

Mar 5, 2020

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

Mar 5, 2020

ObsEva Announces Year End 2019 Financial Results and Business Update

Mar 5, 2020

Heather Rowe Armstrong Joins Arcutis as Vice President of Investor Relations and Corporate Communications

Mar 5, 2020

Passage Bio Appoints Athena Countouriotis to Board of Directors

Mar 4, 2020

Fusion Pharmaceuticals Announces Appointment Of Steven Gannon To Board Of Directors

Mar 3, 2020

Prevail Therapeutics Provides Clinical Advancement Update on PR001 for the Treatment of Parkinson’s Disease with GBA1 mutations

Mar 3, 2020

Sierra Oncology Reports 2019 Year End Results

Mar 2, 2020

ORIC PHARMACEUTICALS APPOINTS MARDI C. DIER TO ITS BOARD OF DIRECTORS

Mar 2, 2020

Prevail Therapeutics Announces Investigational New Drug Application Active for PR006 for the Treatment of Frontotemporal Dementia with GRN Mutation

Feb 28, 2020

Graybug Vision presents preclinical results for GB-401, a potential sustained-delivery treatment of up to six months for primary open angle glaucoma, at the American Glaucoma Society Annual Meeting

Feb 27, 2020

MapKure, BeiGene and SpringWorks Announce Initiation of Phase 1 Clinical Trial of BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors

Feb 27, 2020

Verona Pharma Reports Financial Results for the Full Year Ended December 31, 2019 and Provides Corporate Update

Feb 27, 2020

Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update

Feb 27, 2020

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results

Feb 27, 2020

ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL AND SPECIAL

Feb 27, 2020

Glaukos Corporation Announces Fourth Quarter and Full Year 2019 Financial Results

Feb 27, 2020

BELLUS Health Reports Full Year 2019 Financial Results and Business Highlights on BLU-5937

Feb 27, 2020

Tricida Announces Fourth Quarter and Full-Year 2019 Financial Results

Feb 27, 2020

Passage Bio Announces Pricing of Initial Public Offering

Feb 26, 2020

Numerous Presentations to Showcase Long-Term Efficacy & Safety of Glaukos Technologies at 2020 American Glaucoma Society Meeting

Feb 26, 2020

Gemini Therapeutics and Singapore Eye Research Institute Enter Into Research Collaboration to Explore New Targets for Age-related Macular Degeneration

Feb 25, 2020

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2019 Financial Results and Provides 2020 Guidance

Feb 24, 2020

Aeglea BioTherapeutics Reports Fourth-Quarter and Full-Year 2019 Financial Results, Highlights Recent Milestones

Feb 20, 2020

Turning Point Therapeutics Names Siegfried Reich as Executive Vice President and Chief Scientific Officer

Feb 19, 2020

resTORbio Announces Interim Results for Phase 1b/2a Trial of RTB101 in Patients with Parkinson’s Disease and Provides Corporate Update

Feb 18, 2020

Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer

Feb 14, 2020

CTI BioPharma Announces Commencement of Rights Offering

Feb 14, 2020

Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research

Feb 14, 2020

Xenon Pharmaceuticals Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares

Feb 13, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1b/2 Clinical Trial of Ciforadenant at the 2020 American Society of Clinical Oncology’s Genitourinary Cancers Symposium

Feb 13, 2020

Arcutis Announces Enrollment of First Patient in Topical Roflumilast Cream Phase 3 Open Label Extension Study in Plaque Psoriasis

Feb 12, 2020

X4 Pharmaceuticals Granted New Composition of Matter Patent for Late-Stage Clinical Candidate Mavorixafor

Feb 12, 2020

Prevail Therapeutics’ PR001 Receives Orphan Drug Designation and Rare Pediatric Disease Designation from FDA

Feb 12, 2020

Kala Pharmaceuticals Reports Fourth Quarter And Full Year 2019 Financial Results

Feb 10, 2020

Intellia Therapeutics Presents New Data From Its Engineered Cell Therapy and In Vivo Programs at Keystone Symposia’s Engineering the Genome Conference

Feb 10, 2020

Essa Pharma Announces Multiple Abstracts Accepted For Presentation At Upcoming Medical And Scientific Symposia

Feb 7, 2020

Adaptimmune Therapeutics plc Announces Full Exercise and Closing of Underwriters’ Option to Purchase Additional American Depositary Shares

Feb 7, 2020

Aerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Product Candidate When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension

Feb 6, 2020

VectivBio Adds Commercial Expertise with the Appointment of Kevin Harris as Chief Commercial Officer

Feb 6, 2020

Fusion Pharmaceuticals Announces Appointment Of Pablo J. Cagnoni, M.D., To Board Of Directors

Feb 6, 2020

Sierra Oncology Completes Conversion of Preferred to Common Stock and Issues Stock to Gilead

Feb 6, 2020

Sonendo® Appoints Andrew Kirkpatrick as Chief Operating Officer

Feb 6, 2020

Imara Appoints Joelle Lufkin, M.P.H., as Senior Vice President of Development

Feb 5, 2020

Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia

Feb 4, 2020

Arcutis Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Feb 4, 2020

TELA Bio Announces Publication of Results from In-Vivo Study Demonstrating Favorable Response to Reinforced Biologics in Hernia Repair

Feb 3, 2020

Valneva Announces New $85 Million Financing Arrangement with Leading US Healthcare Funds Deerfield and OrbiMed

Feb 3, 2020

OrbiMed Announces New General Partner

Feb 3, 2020

Alector Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Feb 3, 2020

Verona Pharma Announces Senior Management Changes

Feb 3, 2020

Galecto Appoints Industry Leader Bertil Lindmark, MD, PhD, as Chief Medical Officer

Feb 3, 2020

CTI BioPharma Establishes Accelerated Approval Pathway for Pacritinib in Treating Myelofibrosis Patients With Severe Thrombocytopenia

Feb 3, 2020

Inspire Medical Systems, Inc. Announces Medicare Policy Release Dates and New Draft Local Coverage Determination for Remaining Region

Feb 1, 2020

Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum

Jan 30, 2020

Synlogic Appoints Dr. Michael Burgess to its Board of Directors

Jan 29, 2020

Verrica Pharmaceuticals Announces the Hiring of Two Vice Presidents to Further Grow its Commercial Capabilities

Jan 29, 2020

TELA Bio Announces Appointment of New Chief Commercial Officer

Jan 28, 2020

Ikena Oncology Announces Dosing of First Patient in Phase 1 Study Evaluating IK-175 in Patients with Advanced Solid Tumors

Jan 28, 2020

Alector Announces Initiation of Phase 1b Study of AL003 in Alzheimer’s Disease Patients

Jan 28, 2020

Passage Bio Appoints Bruce Goldsmith, Ph.D. as Chief Executive Officer

Jan 27, 2020

ReViral’s Phase 2a RSV Study publication selected as Editor’s Pick in February 2020 issue of ASM’s Antimicrobial Agents and Chemotherapy

Jan 27, 2020

Alector Announces Proposed Public Offering of Common Stock

Jan 27, 2020

ORIC Pharmaceuticals Announces First Patient Dosed in Phase 1b Clinical Trial of ORIC-101 in Combination with XTANDI® for the Treatment of Prostate Cancer in Collaboration with Astellas

Jan 27, 2020

Harmony Biosciences Secures $200 Million Debt Facility

Jan 24, 2020

Alpine Immune Sciences Presents New Preclinical Data at 2020 Crohn's & Colitis Congress ALPN-101 demonstrates efficacy in treatment of chronic inflammatory bowel disease in both in vivo and in vitro models

Jan 23, 2020

Turning Point Therapeutics Names Garry Nicholson to Its Board of Directors

Jan 22, 2020

TigerConnect Names New Chief Technology Officer as it Accelerates Product Innovation

Jan 22, 2020

Adaptimmune Therapeutics plc Prices Public Offering of American Depositary Shares

Jan 22, 2020

Sierra Oncology Announces Reverse Stock Split

Jan 22, 2020

Xenon Pharmaceuticals Announces Pricing of $60.0 Million Public Offering of Common Shares

Jan 21, 2020

Arcutis Announces ARQ-154 Program for Scalp Psoriasis and Enrollment of First Patient in Phase 2b Clinical Trial

Jan 18, 2020

Verrica Pharmaceuticals Announces Presentation of Positive Data from New Pooled Analysis of Phase 3 CAMP Trials of VP-102

Jan 15, 2020

Patricia Turney Joins Arcutis as Senior Vice President, Manufacturing

Jan 15, 2020

Kala Pharmaceuticals Announces Completion of Enrollment of STRIDE 3 Trial for EYSUVIS™ (KPI-121 0.25%) for Dry Eye Disease

Jan 14, 2020

Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies

Jan 14, 2020

Adimab Extends Platform Partnership with Novo Nordisk

Jan 13, 2020

Allogene Therapeutics and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate ALLO-715 in Combination with Nirogacestat in Multiple Myeloma

Jan 13, 2020

Adimab Provides 2019 Update on Clinical Pipeline

Jan 13, 2020

Aeglea BioTherapeutics Submits CTA Application for its Novel Engineered Human Enzyme Designed to Treat Homocystinuria (ACN00177)

Jan 13, 2020

ObsEva and Yuyuan BioScience Technology Announce Sublicense Agreement to Develop and Commercialize Nolasiban in the People’s Republic of China

Jan 13, 2020

KaNDy Therapeutics Announces Positive Phase 2b Data in Post-Menopausal Women with its Lead Non-Hormonal Product NT-814

Jan 13, 2020

Turning Point Therapeutics Announces Program Updates and Milestones for 2020

Jan 13, 2020

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2020 and Provides Corporate Update

Jan 13, 2020

Arcutis Announces Exercise of Option for Exclusive License to Highly Selective JAK1 Inhibitor for All Topical Dermatological Uses in U.S., Canada, Europe and Japan

Jan 13, 2020

Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications

Jan 13, 2020

Fusion Pharmaceuticals Announces Investment from Canada Pension Plan Investment Board (CPPIB)

Jan 13, 2020

Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership

Jan 13, 2020

Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy

Jan 12, 2020

Ascendis Pharma A/S Provides Pipeline Update and Reviews Progress Towards Vision 3x3 at 38th Annual J.P. Morgan Healthcare Conference

Jan 10, 2020

TELA Bio Announces Preliminary Revenue for Fourth Quarter and Full Year 2019

Jan 10, 2020

Passage Bio Appoints Sandip Kapadia to Board of Directors

Jan 10, 2020

TERNS PHARMACEUTICALS PRESENTS RESULTS FROM AN ONGOING PHASE 1 CLINICAL TRIAL OF TERN-201, A SSAO INHIBITOR IN DEVELOPMENT FOR NASH

Jan 10, 2020

Adimab Provides Year-End Update on 2019 Partnership Activities

Jan 9, 2020

Intellia Therapeutics Highlights Recent Progress and Anticipated 2020 Milestones

Jan 9, 2020

Synlogic Outlines Upcoming Milestones for Clinical Programs and Unveils New Preclinical Pipeline Programs

Jan 9, 2020

Aspen Neuroscience Announces Board of Directors and Scientific Advisory Board

Jan 9, 2020

Prevail Therapeutics Provides PR001 Program Update

Jan 9, 2020

Gemini Therapeutics Enrolls First Patient in Phase 1 Study of GEM103 for Dry Age-related Macular Degeneration

Jan 9, 2020

Turning Point Therapeutics Announces Management Transition

Jan 8, 2020

Nabriva Therapeutics Receives FDA Acknowledgement of New Drug Application Resubmission for Intravenous CONTEPO™ (fosfomycin) for Injection

Jan 8, 2020

Arcutis Announces Enrollment of First Patients in Two Pivotal Phase 3 Clinical Trials Evaluating ARQ-151 as a Potential Once Daily Topical Treatment for Plaque Psoriasis

Jan 8, 2020

Topical Ocular Formulation of Aerpio Pharmaceutical's AKB-9778 Product Candidate Produced IOP Lowering with Minimal Hyperemia When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension in Phase 1b Trial

Jan 7, 2020

VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases

Jan 7, 2020

Galecto and PharmAkea merge to create strong clinical-stage company developing first-in-class therapeutics in fibrosis and cancer

Jan 7, 2020

Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations

Jan 6, 2020

Turning Point Therapeutics Names Homa Yeganegi Senior Vice President, Project Team Leader and Head of Medical Affairs

Jan 6, 2020

Alector Initiates First-in-Human Dosing in Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases

Jan 6, 2020

Sonendo® Announces Growth Investment from EW Healthcare Partners

Jan 6, 2020

Arcutis Biotherapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering

Dec 31, 2019

HLS Therapeutics Announces Health Canada Approval for Vascepa® to Reduce the Risk of Cardiovascular Events

Dec 30, 2019

X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor in Combination with Ibrutinib for the Treatment of Waldenström’s Macroglobulinemia (WM)

Dec 30, 2019

Principia Updates PRN1008 Pemphigus Clinical Program

Dec 20, 2019

Alector Added to the NASDAQ Biotechnology Index

Dec 20, 2019

Nabriva Therapeutics Resubmits New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection

Dec 20, 2019

Nabriva Therapeutics Announces $20 Million Registered Direct Offering

Dec 13, 2019

Alector Showcases Progress in Immuno-Neurology Clinical Programs and Research Portfolio at R&D Day

Dec 13, 2019

Alector Appoints Dr. Richard Scheller, Lasker Prize Awarded Scientist, and Dr. Thomas Südhof, Nobel Laureate as Co-Chairs of its Strategic Portfolio Advice and Review Committee

Dec 12, 2019

Selecta Biosciences Announces Completion of Enrollment in Head-to-Head COMPARE Trial of SEL-212

Dec 12, 2019

Selecta Biosciences Announces $70 Million Private Placement

Dec 12, 2019

AskBio Licenses Rights to Selecta Biosciences’ ImmTOR™ Immune Tolerance Platform for the Treatment of Pompe Disease

Dec 11, 2019

Alector Announces Appointment of Shehnaaz Suliman, M.D., MBA, M.Phil., as President and Chief Operating Officer

Dec 11, 2019

PMV Pharma Appoints Leila Alland, M.D., as Chief Medical Officer

Dec 9, 2019

ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix

Dec 9, 2019

Alpine Immune Sciences Presents ALPN-101 Phase 1 Healthy Volunteer Study Data and Details of Upcoming Phase I/II BALANCE GVHD Study at the 61st American Society of Hematology Annual Meeting

Dec 9, 2019

CTI BioPharma Announces Presentation of Data Supporting Pacritinib's Benefit in Myelofibrosis Patients with Severe Thrombocytopenia at the 61st American Society of Hematology Meeting

Dec 8, 2019

Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion

Dec 7, 2019

Principia Presents Consistent Positive Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial

Dec 7, 2019

Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual Meeting

Dec 6, 2019

Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting

Dec 5, 2019

Alector Announces FDA Fast Track Designation Granted to AL001 for the Treatment of Patients with Frontotemporal Dementia

Dec 4, 2019

TransMedics’ Organ Care System (OCS™) Technology Used in First U.S. Adult Human Heart Transplants From DCD Donors

Dec 3, 2019

Tricida Announces Hiring of Elizabeth Faust, Ph.D., as Senior Vice President of Medical Affairs

Dec 3, 2019

Regenerative Medicine Advanced Therapy Designation Granted by FDA to ADP?A2M4 for the Treatment of Synovial Sarcoma

Nov 27, 2019

ReViral Appoints Lawrence Blatt and Richard N. Kender to its Board of Directors

Nov 26, 2019

X4 Pharmaceuticals Prices $65 Million Public Offering of Common Stock and Class B Warrants

Nov 25, 2019

X4 Pharmaceuticals Announces Proposed Public Offering

Nov 21, 2019

Harpoon Therapeutics And Abbvie Announce Licensing And Option Collaboration To Advance Hpn217, Harpoon’s Bcma-Targeting Tritac®, And Expand Existing Discovery Collaboration

Nov 21, 2019

Glaukos Completes Acquisition of Avedro, Inc.

Nov 21, 2019

Selecta Biosciences Appoints Carrie S. Cox as Chairman of its Board of Directors

Nov 21, 2019

Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors

Nov 19, 2019

Verrica Pharmaceuticals Announces Passing of Board of Directors Member Glenn Oclassen

Nov 19, 2019

NextCure Announces Closing of Public Offering

Nov 18, 2019

Phase 2a Study Published in Antimicrobial Agents and Chemotherapy Shows Potential of Sisunatovir (RV521) to Combat Respiratory Syncytial Virus Infection

Nov 18, 2019

Ascendis Pharma A/S Reports Third Quarter 2019 Financial Results

Nov 18, 2019

Prevail Therapeutics Announces Appointment of Morgan Sheng, Ph.D., to Board of Directors

Nov 18, 2019

Nabriva Therapeutics Commends the CDC on the 2019 Antibiotic Resistance Threats Report, Highlighting the Need for New Antibiotics Aligned with Antibiotic Stewardship

Nov 16, 2019

Updated Data from Phase 1 ADP-A2M4 Trial Demonstrating Continued Clinical Benefit for People with Synovial Sarcoma

Nov 15, 2019

resTORbio Announces That the Phase 3 PROTECTOR 1 Trial of RTB101 in Clinically Symptomatic Respiratory Illness Did Not Meet the Primary Endpoint

Nov 14, 2019

Tricida Announces Third Quarter 2019 Financial Results

Nov 14, 2019

Tricida Announces FDA Acceptance of New Drug Application for Veverimer

Nov 14, 2019

NextCure Announces Pricing of Public Offering of Common Stock

Nov 14, 2019

BELLUS Health Reports Financial and Operating Results for the Third Quarter Ended September 30, 2019

Nov 14, 2019

Verona Pharma plc: PDMR Dealing – Purchase by Chairman

Nov 14, 2019

Arcutis Appoints Keith Klein as General Counsel

Nov 14, 2019

Ascendis Pharma Expands TransCon™ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARA® in the United States

Nov 13, 2019

PMV Pharma Secures $62 Million in Series C Financing To Develop Cancer Drugs Targeting p53

Nov 12, 2019

Alpine Immune Sciences Presents New ALPN-101 Preclinical Data at the 2019 American College of Rheumatology (ACR) Annual Meeting

Nov 12, 2019

Crinetics Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Nov 12, 2019

Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of Repotrectinib in Pediatric Patients

Nov 12, 2019

Synlogic Provides Program and Business Update and Reports Third Quarter 2019 Financial Results

Nov 12, 2019

X4 Pharmaceuticals Receives Breakthrough Therapy Designation from the FDA for Mavorixafor for the Treatment of WHIM Syndrome

Nov 12, 2019

scPharmaceuticals Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update

Nov 12, 2019

SpringWorks Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights

Nov 12, 2019

Alector Reports Recent Business Highlights and Third Quarter 2019 Financial Results

Nov 12, 2019

NextCure Reports Third Quarter 2019 Financial Results

Nov 12, 2019

Prevail Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights

Nov 12, 2019

Nabriva Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

Nov 11, 2019

Selecta Biosciences Presents New Data at 2019 American College of Rheumatology Annual Meeting from Phase 2 Study of SEL-212 for the Treatment of Patients with Chronic Refractory Gout

Nov 11, 2019

89bio Announces Pricing of Upsized Initial Public Offering

Nov 11, 2019

SI-BONE, Inc. Reports Third Quarter 2019 Financial Results and Updates Full-Year 2019 Revenue Guidance

Nov 11, 2019

Foamix and Menlo Therapeutics to Merge, Creating a Combined Company Focused on the Development and Commercialization of Therapeutics for Dermatologic Indications

Nov 11, 2019

Turning Point Therapeutics Initiates Phase 1/2 Clinical Study of TPX-0046, a Novel RET/SRC Inhibitor

Nov 9, 2019

NextCure Presents Updated Clinical Data from NC318 Phase 1/2 Clinical Trial at the 34th Annual Meeting of Society for Immunotherapy of Cancer (SITC) and Announces Initiation of Phase 2 Portion of the Trial

Nov 8, 2019

Selecta Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Nov 8, 2019

Alpine Immune Sciences Presents New Preclinical Data at The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting

Nov 8, 2019

Corvus Pharmaceuticals Presents Updated Data from CPI-006 Phase 1/1b Clinical Trial at 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 7, 2019

Obseva Announces That Nolasiban Implant 4 Study Did Not Meet Primary Endpoint

Nov 7, 2019

TELA Bio Announces Pricing of Initial Public Offering of Common Stock

Nov 7, 2019

ObsEva Announces Third Quarter 2019 Financial Results

Nov 7, 2019

Aerpio Reports Third Quarter 2019 Financial Results and Provides Business Update

Nov 7, 2019

X4 Pharmaceuticals Reports Third Quarter 2019 Financial Results and Recent Business Highlights

Nov 7, 2019

Kala Reports Third Quarter 2019 Financial Results

Nov 7, 2019

Audentes Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Nov 6, 2019

Arvinas Announces Pricing of Public Offering of Common Stock

Nov 6, 2019

Harpoon Therapeutics Reports Third Quarter 2019 Financial Results And Provides Corporate Update

Nov 6, 2019

Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update

Nov 6, 2019

Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2019 Financial Results

Nov 6, 2019

Verrica Pharmaceuticals Reports Third Quarter 2019 Financial Results

Nov 6, 2019

Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights

Nov 6, 2019

Ascendis Pharma A/S Announces First Presentation of Preclinical Data Utilizing TransCon™ Technology in Oncology at SITC 2019

Nov 6, 2019

Alpine Immune Sciences Announces Oral Presentation of ALPN-101 at the 61st American Society of Hematology Annual Meeting and Exposition

Nov 6, 2019

Arvinas Announces Proposed Offering of Common Stock

Nov 5, 2019

X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor for the Treatment of Severe Congenital Neutropenia

Nov 5, 2019

Xenon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Nov 5, 2019

Synthorx Reports Third Quarter Financial Results

Nov 5, 2019

Silverback Therapeutics to Present Preclinical Data at SITC 34th Annual Meeting Demonstrating SBT6050’s Potential for Robust Single Agent Activity in Tumors Refractory to Checkpoint Inhibition

Nov 5, 2019

Principia Biopharma reports third quarter financial results

Nov 5, 2019

Inspire Medical Systems, Inc. Announces Third Quarter 2019 Financial Results and Increases 2019 Outlook

Nov 5, 2019

resTORbio Reports Third Quarter 2019 Financial Results and Corporate Update

Nov 5, 2019

Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2019

Nov 4, 2019

Arvinas Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Nov 4, 2019

Turning Point Therapeutics Reports Third Quarter 2019 Financial and Operational Results

Nov 4, 2019

X4 Pharmaceuticals Appoints Derek Meisner, J.D., as General Counsel

Nov 4, 2019

SI-BONE Announces Medicare Physician Payment Increase of 27% for Minimally Invasive SI Joint Fusion

Nov 4, 2019

CTI BioPharma Reports Third Quarter 2019 Financial Results

Nov 4, 2019

Aeglea BioTherapeutics Strengthens Leadership Team with Appointment of Ravi M. Rao as Chief Medical Officer and Michael C. Hanley as Chief Commercial Officer

Nov 1, 2019

ObsEva Announces Clearance to Initiate Pivotal US Phase 3 Clinical Trial (IMPLANT 3) of Nolasiban in Women Undergoing Embryo Transfer Following IVF

Oct 31, 2019

Intellia Therapeutics Announces Third Quarter 2019 Financial Results

Oct 31, 2019

Promentis Pharmaceuticals Announces Positive Results for Phase 2A Study of SXC-2023 Targeting Novel Glutamatergic Mechanism and Completion of Enrollment for Phase 2 Trichotillomania Study

Oct 30, 2019

Alpine Immune Sciences Completes Enrollment of Phase I Study of ALPN-101 and Announces Third Quarter Conference Call

Oct 30, 2019

Arcutis Announces Addition of Three Senior Biopharmaceutical Executives to Management Team

Oct 29, 2019

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results

Oct 29, 2019

Harpoon Therapeutics Presents Preclinical Data For Hpn328, A Dll3-Targeting T Cell Engager, At Aacr-Nci-Eortc International Conference On Molecular Targets And Cancer Therapeutics

Oct 29, 2019

Passage Bio Appoints Richard Morris as Chief Financial Officer

Oct 29, 2019

Selecta Biosciences Presents New Preclinical Data from its Gene Therapy Program at 2019 ESGCT Annual Congress

Oct 28, 2019

ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at AACR-NCI-EORTC Annual Conference

Oct 28, 2019

ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oct 24, 2019

Arcutis Biotherapeutics Announces Positive End-of-Phase 2 Meeting with FDA and Planned Initiation of Phase 3 Program for ARQ-151 for Plaque Psoriasis

Oct 24, 2019

Intellia Therapeutics Presents In Vivo and Ex Vivo Data at the 2019 Annual Congress of the European Society of Gene and Cell Therapy (ESGCT)

Oct 24, 2019

SpringWorks Therapeutics Announces Initiation of Phase 2b ReNeu Clinical Trial of Mirdametinib in Children and Adults with Neurofibromatosis Type 1 (NF1)-Associated Plexiform Neurofibromas (NF1-PN)

Oct 24, 2019

Compass Therapeutics to Present Preclinical Data on a Novel PD-1/PD-L1 Bispecific Antibody and from its Proprietary Innate Cell Engager Platform at the 2019 SITC Meeting

Oct 23, 2019

Avera eCARE® Selects Tyto Care as an Enterprise Solution for Virtual Care

Oct 23, 2019

Arvinas presents a platform update, including initial data from the first two clinical trials of protac targeted protein degraders

Oct 22, 2019

Harpoon therapeutics announces presentation on HPN328 at AACR-NCI-EORTC international conference on molecular targets and cancer therapeutics

Oct 22, 2019

Compass Therapeutics Appoints Leading Immuno-Oncology Researchers to Its Immuno-Oncology Scientific Advisory Board

Oct 21, 2019

Aerpio Pharmaceuticals Announces Review of Strategic Alternatives

Oct 21, 2019

Arcutis Announces the Completion of $94.5 million Series C Financing

Oct 21, 2019

ReViral Announces Appointment of Alan Musso as Chief Financial Officer

Oct 21, 2019

Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe

Oct 18, 2019

Verrica Pharmaceuticals Announces Presentation of Positive Data from Clinical Trials of VP-102 at the 2019 39th Annual Fall Clinical Dermatology Conference

Oct 18, 2019

Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers

Oct 18, 2019

ESSA Announces Changes to its Board of Directors

Oct 17, 2019

Verona Pharma Completes Enrollment in Phase 2b Clinical Trial with Nebulized Ensifentrine in moderate-to-severe COPD

Oct 17, 2019

Enyo pharma announces multiple EYP001 data presentations at AASLD conference

Oct 16, 2019

Novant Health and Tyto Care Partner to Provide Unique Digital Health Offerings

Oct 16, 2019

Natera Announces Pricing of Follow-On Offering

Oct 15, 2019

Terns pharmaceuticals to present postive preclinical data on fxr agonist TERN-101 at the liver meeting 2019

Oct 15, 2019

Principia Announces Pricing of Public Offering of Common Stock

Oct 15, 2019

Principia Announces Proposed Public Offering of Common Stock

Oct 15, 2019

Principia Announces Positive Preliminary Data of PRN1008 For Immune Thrombocytopenia in Ongoing Phase 1/2 Trial

Oct 10, 2019

Principia Announces Positive Preliminary Data of PRN1008 From Its Ongoing Phase 2 Part B Trial in Pemphigus

Oct 10, 2019

Aerpio Pharmaceuticals Announces Interim Results from its Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma

Oct 9, 2019

Adaptimmune and Cryoport Announce Agreement to Ensure Safe and Fully Monitored Transport of Adaptimmune’s Cell Therapies

Oct 9, 2019

Verrica Pharmaceuticals Appoints Eugene Scavola to the Position of Executive Vice President, Technical Operations

Oct 9, 2019

TigerConnect Recognized as One of the Best Places to Work in Healthcare for the Fifth Consecutive Year

Oct 9, 2019

Arcutis Announces Enrollment of Last Patient in Phase 2a Clinical Trial of ARQ-151 Cream as a Potential Topical Treatment for Atopic Dermatitis

Oct 8, 2019

Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases

Oct 7, 2019

Verrica Pharmaceuticals Announces Leadership Team Update

Oct 5, 2019

Audentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked Myotubular Myopathy (XLMTM), at the 24th International Annual Congress of the World Muscle Society

Oct 3, 2019

Enyo pharma announces move to new corporate headquarters

Oct 2, 2019

Arvinas strengthens scientific advisory board with leaders in oncology and neurological disorders

Oct 2, 2019

NextCure Announces Promotion of Timothy Mayer, Ph.D., to Chief Operating Officer

Oct 2, 2019

resTORbio Presents New Findings on RTB101 During Late-Breaking Session at IDWeek 2019

Oct 2, 2019

Adicet Bio Raises $80M in Series B Financing

Oct 2, 2019

Graybug Vision Initiates Phase 2b (ALTISSIMO) Clinical Trial of GB-102 in Patients with Wet Age-Related Macular Degeneration

Oct 1, 2019

Constellation Pharmaceuticals Announces $65 Million Private Placement with New and Existing Investors

Oct 1, 2019

Bayer and Arvinas unveil targeted protein degradataion joint venture, Oerth Bio

Oct 1, 2019

Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer

Oct 1, 2019

CTI BioPharma Begins Patient Enrollment in PACIFICA Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis Patients With Severe Thrombocytopenia

Sep 30, 2019

Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO

Sep 30, 2019

European Respiratory Society International Congress, Madrid 29 September 2019

Sep 30, 2019

Audentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including New Data From ASPIRO, the Clinical Trial Evaluating AT132 in Patients With X-Linked Myotubular Myopathy (XLMTM)

Sep 30, 2019

Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPX-0046, a Novel RET/SRC Inhibitor

Sep 30, 2019

X4 Pharmaceuticals Reports Positive Data from Phase 2a Trial of Mavorixafor in Combination with Axitinib in Advanced Clear Cell Renal Cell Carcinoma Patients

Sep 28, 2019

ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress

Sep 27, 2019

Lefamulin Evaluation Against Pneumonia 2 (LEAP 2) Study Results Published in the Journal of the American Medical Association

Sep 26, 2019

Inspire Medical Systems, Inc. Announces Additional Draft Local Coverage Determinations Proposing Coverage of Inspire Therapy

Sep 26, 2019

Arbitration Decision Affirms Intellia Therapeutics’ Interpretation of Licensing Agreement with Caribou Biosciences on the CRISPR/Cas9 Technology

Sep 25, 2019

89bio Announces Dosing of First Patients in NASH Study and Issuance of Composition of Matter Patent

Sep 25, 2019

SI-BONE, Inc. Announces Publication of Five-Year Prospective Study Results on 103 Patients Treated with Triangular Titanium iFuse Implant System

Sep 24, 2019

European Commission Grants Orphan Drug Designation for Nirogacestat for the Treatment of Soft Tissue Sarcoma

Sep 24, 2019

Constellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise

Sep 24, 2019

Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring

Sep 23, 2019

X4 Pharmaceuticals Appoints William E. Aliski to Board of Directors

Sep 23, 2019

Adicet Bio Appoints Francesco Galimi, M.D., Ph.D., SVP and Chief Medical Officer

Sep 23, 2019

Passage Bio Grows Management Team with Chief Medical Officer and General Counsel Appointments

Sep 19, 2019

Prevail Therapeutics Announces Addition to Russell 2000®, 3000® and Microcap® Indexes

Sep 18, 2019

Arcutis, Inc.’s Development Program for Eczema

Sep 18, 2019

scPharmaceuticals Inc. Provides FUROSCIX® Update and Announces Completion of $20.0 Million Term Loan Agreement

Sep 18, 2019

Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion

Sep 18, 2019

X4 Pharmaceuticals Appoints Renato Skerlj, Ph.D. as Senior Vice President of Research and Development

Sep 17, 2019

BELLUS Health Announces Exercise of Over-Allotment Option in Connection With Underwritten Public Offering of Common Shares

Sep 17, 2019

SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Shares

Sep 17, 2019

Xenon Announces Appointment of Shelley McCloskey as Senior Vice President, Human Resources

Sep 17, 2019

Edgewise Therapeutics Closes $50 Million Series B Financing

Sep 16, 2019

Verrica Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for VP-102 for the Treatment of Molluscum Contagiosum

Sep 13, 2019

Imara Submits Confidential Draft Registration Statement for Proposed Initial Public Offering

Sep 13, 2019

Gemini Therapeutics Announces Leadership Appointment

Sep 12, 2019

Tricida Launches Metabolic Acidosis Insights, an Online Educational Resource for the Healthcare Community

Sep 12, 2019

SpringWorks Therapeutics Announces Pricing Of Initial Public Offering

Sep 12, 2019

Ascendis Pharma A/S Announces Presentations on Achondroplasia and TransCon™ CNP at International Skeletal Dysplasia Society Meeting

Sep 11, 2019

Boost Epi-On™ Corneal Cross-Linking Data to Be Presented at the 37th Congress of the ESCRS

Sep 11, 2019

ObsEva announces new composition of its Executive Committee

Sep 10, 2019

Prevail Therapeutics Provides Program Update on PR001 in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease

Sep 10, 2019

ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer

Sep 9, 2019

Passage Bio Announces New Gene Therapy Development Program for Patients with Charcot-Marie-Tooth Neuropathy Type 2A

Sep 9, 2019

BELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United States

Sep 9, 2019

Natera Publishes Largest NIPT Outcomes Study Demonstrating Robust Clinical Performance Over a 4-year Period

Sep 9, 2019

Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexion’s Acquisition of an Investigational NaV1.7 Inhibitor for the Treatment of Post-Operative Pain

Sep 9, 2019

Enyo Pharma Announces New CFO and Provides Clinical Pipelien Update

Sep 9, 2019

United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4

Sep 9, 2019

Alector Initiates Phase 2 Trial of AL001 in Patients with Frontotemporal Dementia

Sep 9, 2019

Nabriva’s XENLETA™ (lefamulin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP) Now Available in the U.S.

Sep 6, 2019

Nabriva Therapeutics Earns $5 Million Milestone Payment under its License Agreement with Sinovant Sciences

Sep 5, 2019

BELLUS Health Announces Pricing of US$70 Million Public Offering in Canada and the United States

Sep 5, 2019

Turning Point Therapeutics Announces Pricing of Public Offering of Common Stock

Sep 4, 2019

Synlogic Announces Appointments of New CMO, Head of Regulatory Affairs, and CFO Departure

Sep 4, 2019

Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease

Sep 4, 2019

Passage Bio Closes $110 Million Series B Financing

Sep 4, 2019

Synlogic Presents Data from Phase 1/2a Study of SYNB1618 at the Annual Symposium of the Society for the Study of Inborn Errors of Metabolism (SSIEM)

Sep 4, 2019

Selecta Biosciences Appoints Brad Dahms as Chief Financial Officer

Sep 3, 2019

BELLUS Health Announces the Launch of a US$60 Million Public Offering of Common Shares in Canada and the United States and the Filing of an Application to List Its Common Shares on Nasdaq

Sep 3, 2019

Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib and Preclinical Data for TPX-0046, a Novel RET/SRC Inhibitor

Sep 3, 2019

Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium

Sep 3, 2019

ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of Action, Supporting Its Potential to Increase Live Birth Rate Following Embryo Transfer in IVF

Sep 3, 2019

Turning Point Therapeutics Announces Proposed Public Offering of Common Stock

Sep 3, 2019

SI-BONE, Inc. Announces Wellmark Blue Cross Blue Shield Establishes Positive Coverage for MIS SI Joint Fusion Using iFuse

Aug 30, 2019

SpringWorks Therapeutics Appoints Alan Fuhrman to its Board of Directors

Aug 30, 2019

Principia Biopharma Appoints Shawn Tomasello to its Board of Directors

Aug 29, 2019

SpringWorks Therapeutics Receives Breakthrough Therapy Designation for Nirogacestat for the Treatment of Adult Patients with Progressive, Unresectable, Recurrent or Refractory Desmoid Tumors

Aug 29, 2019

Inspire Medical Systems, Inc. Announces Additional Draft Local Coverage Determinations Proposing Coverage of Inspire Therapy

Aug 28, 2019

Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results

Aug 27, 2019

Cyrus Biotechnology Offers CryoEM Services based on First-in-class, Peer-reviewed Rosetta Software Methods

Aug 27, 2019

NeRRe Therapeutics Announces Publication of Positive Results in a Phase 2 Pilot Study of Orvepitant in Chronic Refractory Cough

Aug 27, 2019

Pionyr Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages

Aug 27, 2019

Arvinas announces the initiation of patient dosing in a first-in-human phase 1 study of ARV-471, an estrogen receptor-targeting protac protein degrader

Aug 27, 2019

ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Process of US$36 Million

Aug 27, 2019

Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients

Aug 26, 2019

BELLUS Health Strengthens Leadership Team with Appointment of Dr. Catherine Bonuccelli, MD as Chief Medical Officer

Aug 26, 2019

Inspire Medical Systems, Inc. Announces Draft Local Coverage Determinations Proposing Coverage of Inspire Therapy from Two Regional Medicare Administrators

Aug 23, 2019

ESSA Pharma Announces $36 Million Public Offering of Common Stock and Concurrent Private Placement

Aug 22, 2019

Medicare Issues Positive Draft Local Coverage Determination for Natera's Signatera� MRD Test in Colorectal Cancer

Aug 20, 2019

Graybug Vision Secures $80 million of Additional Funding to Advance its Potentially Transformative Retina and Glaucoma Clinical Programs

Aug 20, 2019

Synlogic Discontinues Development of SYNB1020 to Treat Hyperammonemia

Aug 19, 2019

Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta™ (lefamulin) to Treat Community-Acquired Bacterial Pneumonia (CABP)

Aug 16, 2019

Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous CONTEPO™ (fosfomycin) for Injection

Aug 15, 2019

Inspire Medical Systems, Inc. Announces Additional 17.7 Million Covered Lives with Seven New Coverage Policies

Aug 15, 2019

BELLUS Health Announces Share Consolidation

Aug 14, 2019

resTORbio Reports Second Quarter 2019 Financial Results and Corporate Update

Aug 14, 2019

Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

Aug 13, 2019

Imara Expands Management Team and Strengthens Expertise Across Strategic Functions as it Advances IMR-687 for Sickle Cell Disease and Beta Thalassemia

Aug 13, 2019

Crinetics Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Aug 13, 2019

Passage Bio Announces Launch of Natural History Study to Evaluate Patients with GM1 Gangliosidosis

Aug 13, 2019

Alpine Immune Sciences Provides Pipeline Update and Reports Second Quarter 2019 Financial Results

Aug 13, 2019

Inspire Medical Systems, Inc. Announces New Brand Identity and Website to Better Reach Prospective Patients Struggling with Sleep Apnea

Aug 12, 2019

Alector Reports Recent Business Highlights and Second Quarter 2019 Financial Results

Aug 12, 2019

Alector Announces the Addition of Kristine Yaffe, M.D., to the Board of Directors

Aug 8, 2019

Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter Financial Results

Aug 8, 2019

Kala Pharmaceuticals Receives FDA Complete Response Letter for KPI-121 0.25% NDA and Plans To Repond with Data from Stride 3 Trial

Aug 8, 2019

ORIC Pharmaceuticals Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance

Aug 8, 2019

Tricida Announces Second Quarter 2019 Financial Results

Aug 8, 2019

Selecta Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Aug 8, 2019

BELLUS Health Reports Financial and Operating Results for the Second Quarter Ended June 30, 2019

Aug 8, 2019

Synlogic Reports Second Quarter 2019 Financial Results and Provides Program Updates

Aug 8, 2019

Principia biopharma reports second quarter financial results

Aug 8, 2019

Aerpio Reports Second Quarter 2019 Financial Results and Provides Business Update

Aug 8, 2019

89bio Initiates Phase 1b/2a Proof of Concept Clinical Trial of Investigational Therapy BIO89-100 for the Treatment of NASH

Aug 8, 2019

Nabriva Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights

Aug 7, 2019

Avedro, Inc. Announces Second Quarter 2019 Financial Results

Aug 7, 2019

Verrica Pharmaceuticals Reports Second Quarter 2019 Financial Results

Aug 7, 2019

scPharmaceuticals Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update

Aug 7, 2019

ObsEva Reports Second Quarter 2019 Financial Results

Aug 7, 2019

Glaukos and Avedro Announce Definitive Acquisition Agreement

Aug 7, 2019

Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2019 Financial Results

Aug 7, 2019

Selecta Biosciences Combines ImmTOR™ Platform with AskBio’s Industry-Leading Gene Therapy Platform in Strategic Partnership

Aug 7, 2019

ObsEva SA Announces $75 Million Credit Facility with Oxford Finance LLC

Aug 7, 2019

Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities

Aug 6, 2019

Xenon Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Aug 6, 2019

Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Aug 6, 2019

Inspire Medical Systems, Inc. Announces Second Quarter 2019 Financial Results and Increases 2019 Outlook

Aug 6, 2019

Aeglea BioTherapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights

Aug 6, 2019

Turning Point Therapeutics Reports Second Quarter 2019 Financial and Operational Results

Aug 6, 2019

Verona Pharma plc: Operational Update and Financial Results for the Three and Six Months Ended June 30, 2019

Aug 6, 2019

Kala Pharmaceuticals Reports Second Quarter 2019 Financial Results

Aug 6, 2019

SI-BONE, Inc. Reports Second Quarter 2019 Financial Results

Aug 5, 2019

Arvinas Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Aug 5, 2019

Verona Pharma Reports Positive Phase 2 Results with Dry Powder Inhaler Formulation of Ensifentrine in COPD

Aug 5, 2019

Harpoon Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Aug 1, 2019

Intellia Therapeutics Announces Second Quarter 2019 Financial Results and Company Update

Aug 1, 2019

Compass Therapeutics Appoints Julie Sunderland to Board of Directors

Aug 1, 2019

CTI BioPharma Reports Second Quarter 2019 Financial Results

Aug 1, 2019

Synthorx Reports Second Quarter Financial Results

Aug 1, 2019

Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update

Aug 1, 2019

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2019 Financial Results

Aug 1, 2019

New Executive Team Announced at Adaptimmune

Jul 31, 2019

Turning Point Therapeutics Initiates Phase 1 Clinical Study of Tpx-0022, a Novel Met Inhibitor Targeting Advanced Solid Tumors

Jul 30, 2019

TransMedics Announces Successful Long Distance Retrieval and Transplantation of Donor Lungs from Hawaii Using Organ Care System (OCS�)

Jul 30, 2019

X4 Pharmaceuticals Receives Orphan Drug Designation from European Commission for Mavorixafor for Treatment of WHIM Syndrome

Jul 30, 2019

Foamix Announces $64 Million Capital Financing Investment by Perceptive Advisors and OrbiMed

Jul 30, 2019

Principia announces update to ongoing Phase 2 clinical trial in patients with ITP

Jul 30, 2019

NeuroPace Appoints Mark Saxton as Vice President of Sales

Jul 30, 2019

BELLUS Health Announces First Patient Enrolled in Phase 2 Study of BLU-5937 for the Treatment of Refractory Chronic Cough & Pursuit of Second Indication in Chronic Pruritus

Jul 29, 2019

Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results

Jul 29, 2019

Turning Point Therapeutics Appoints Biotechnology Investment Banker Yi Larson as Executive Vice President and Chief Financial Officer

Jul 29, 2019

Rhythm Pharmaceuticals Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for Setmelanotide for the Treatment of Bardet-Biedl Syndrome

Jul 29, 2019

Crinetics Pharmaceuticals to Receive Final Award of SBIR Grant from NIH Congenital Hyperinsulism

Jul 29, 2019

Arvinas appoints Ronald Peck, M.D as Chief Medical Officer

Jul 26, 2019

ObsEva SA Reports Positive Feedback from Independent Data Monitoring Committee for PROLONG Part B with OBE022

Jul 25, 2019

Passage Bio Expands Executive Management Team

Jul 25, 2019

Arvinas strengthens board of directors with addition of Leslie Norwalk

Jul 25, 2019

Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS

Jul 25, 2019

Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2019 Earnings and Company Update

Jul 25, 2019

Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors

Jul 25, 2019

Inspire Medical Systems, Inc. Announces Changes to its Board of Directors

Jul 24, 2019

Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2019 Financial Results on August 1, 2019

Jul 24, 2019

NeuroPace Announces Michael Favet as CEO

Jul 24, 2019

Health Catalyst Announces Pricing of Initial Public Offering

Jul 24, 2019

Aeglea BioTherapeutics Receives FDA Breakthrough Therapy Designation for Pegzilarginase for Treatment of Arginase 1 Deficiency

Jul 24, 2019

Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707

Jul 24, 2019

Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors

Jul 23, 2019

Marinus Pharmaceuticals Announces Data from Magnolia and Amaryllis Phase 2 Studies in Women with Postpartum Depression

Jul 23, 2019

resTORbio Announces Early Completion of Enrollment of Phase 3 PROTECTOR 1 Trial with RTB101 in Clinically Symptomatic Respiratory Illness

Jul 22, 2019

Arcutis, Inc. Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis

Jul 22, 2019

Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center

Jul 19, 2019

Realm Therapeutics plc Update on Company’s Nasdaq Listing

Jul 18, 2019

Augmedix, powered by Glass, accelerates scaling efforts with the nation’s leading healthcare systems

Jul 18, 2019

Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon™ CNP in Children with Achondroplasia

Jul 18, 2019

CTI BioPharma Announces Outcome From End-of-Phase-2a Meeting With U.S. Food and Drug Administration (FDA) Regarding Pacritinib for Treatment of Myelofibrosis

Jul 18, 2019

ViewRay Announces Conference Call and Webcast of Second Quarter 2019 Financial Results to be Held After Market on August 8, 2019

Jul 18, 2019

Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE?A4 to Enhance Antitumor Responses

Jul 17, 2019

SI-BONE To Report Second Quarter 2019 Financial Results on August 6, 2019

Jul 17, 2019

ObsEva Hosts KOL Meeting on IVF Trends, Unmet Need and Market Potential of Nolasiban

Jul 17, 2019

X4 Pharmaceuticals and Abbisko Therapeutics Enter into Oncology Development and Commercialization Agreement for Mavorixafor in Greater China

Jul 17, 2019

ObsEva appoints industry expert as Chief Medical Officer to further advance its Phase 3 clinical programs

Jul 17, 2019

ObsEva SA Announces Completion of Patient Recruitment in PRIMROSE 1 Phase 3 Clinical Trial of Linzagolix for the Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids

Jul 17, 2019

Alector Announces Data from On-going Phase 1b Trial Demonstrating that AL001 Reverses Progranulin Deficiency in Frontotemporal Dementia Patients

Jul 17, 2019

Rhythm Pharmaceuticals Launches Free Genetic Testing Program for Rare Genetic Disorders of Obesity

Jul 16, 2019

SCPHARMACEUTICALS INC. PROVIDES REGULATORY UPDATE ON FUROSCIX®

Jul 16, 2019

Crinetics Pharmaceuticals appoints Stephanie Okey to Board of Directors

Jul 16, 2019

ViewRay Announces Appointment of Dr. Gail Wilensky to its Board of Directors

Jul 15, 2019

Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with Phenylketonuria and Guides to Next Phase of Development

Jul 15, 2019

Selecta Biosciences Appoints Alison Schecter, M.D., as Chief Medical Officer

Jul 10, 2019

NIH Study to Utilize NeuroPace RNS® System for Research on the Brain’s Reward System

Jul 10, 2019

Passage Bio Announces New Dedicated Gene Therapy Manufacturing Suite

Jul 10, 2019

Pionyr Immunotherapeutics and ProBioGen Initiate a Second Immuno-Oncology Contract Development and Manufacturing Project

Jul 10, 2019

Acutus Medical Announces Addition of Scott Huennekens as Executive Chairman of the Board

Jul 9, 2019

Inspire Medical Systems, Inc. to Report Second Quarter 2019 Financial Results on August 6, 2019

Jul 9, 2019

ORIC Pharmaceuticals Appoints Lori Friedman, PhD, as Chief Scientific Officer

Jul 9, 2019

Inspire Medical Systems, Inc. Announces UnitedHealthcare Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea

Jul 8, 2019

Compass Therapeutics Announces First Patient Dosed in Phase 1 Trial of CTX-471

Jun 27, 2019

SpringWorks Therapeutics Announces Global Clinical Collaboration with GlaxoSmithKline to Evaluate Nirogacestat in Combination with Belantamab Mafodotin in Patients with Relapsed or Refractory Multiple Myeloma

Jun 27, 2019

SI-BONE’s iFuse Implant System Surpasses 40,000 Procedures

Jun 27, 2019

Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer

Jun 26, 2019

X4 Pharmaceuticals Initiates Pivotal Phase 3 Clinical Trial of Mavorixafor for the Treatment of WHIM Syndrome

Jun 26, 2019

Intellia Therapeutics' Statement on Recent U.S. Patent and Trademark Office Actions Relating to Key CRISPR/Cas9 Genome Editing Technology

Jun 26, 2019

Verrica Pharmaceuticals Achieves Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with Common Warts

Jun 25, 2019

Verona Pharma Strengthens its Clinical Team Ahead of Phase 3 Development of Ensifentrine

Jun 25, 2019

Tricida Announces Publication of Positive Long-Term Phase 3 Clinical Trial Results of Veverimer (TRC101) in The Lancet

Jun 24, 2019

Realm Shareholders Approve Scheme of Arrangement for Acquisition by ESSA Pharma Inc. at Court Meeting

Jun 24, 2019

Nabriva Therapeutics Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application for Lefamulin

Jun 20, 2019

Acutus Medical Announces $170 Million Financing

Jun 20, 2019

Selecta Biosciences Announces Appointment of Scott D. Myers to Board of Directors

Jun 20, 2019

Turning Point Therapeutics Initiates Phase 2 Registrational Portion of TRIDENT-1 Clinical Study

Jun 19, 2019

Rhythm Pharmaceuticals Announces Election of Jennifer Good to its Board of Directors

Jun 19, 2019

Prevail Therapeutics Announces Pricing of Initial Public Offering

Jun 19, 2019

Nabriva Therapeutics Submits Type A Meeting Request to FDA for Intravenous CONTEPO™ (fosfomycin) for injection

Jun 19, 2019

ObsEva Progressing Toward U.S. Phase 3 Trial for Nolasiban in IVF Following Recent FDA Meeting

Jun 18, 2019

BeiGene and SpringWorks Therapeutics Announce the Formation of MapKure to Develop BGB-3245, an Investigational, Selective Next-Generation RAF Kinase Inhibitor

Jun 18, 2019

Imara Presented Positive, Interim Phase 2a Data on IMR-687 for the Treatment of Sickle Cell Disease at the 24th Congress of the European Hematology Association

Jun 17, 2019

SI-BONE Announces the Addition of Mark Foley and Heyward Donigan to the Board of Directors

Jun 17, 2019

Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy

Jun 13, 2019

Terns Pharmaceuticals Initiates a Phase 1 Clinical Trial of Tern-101

Jun 13, 2019

PMV Pharma Appoints Deepika Jalota, Pharm.D. as Senior Vice President and Head of Regulatory Affairs

Jun 12, 2019

X4 Pharmaceuticals and Invitae Announce Partnership to Provide No-Cost Genetic Testing to Patients Suspected of Primary Immunodeficiency Disease

Jun 12, 2019

Selecta Biosciences Presents Full Data from Phase 2 Trial of SEL-212 for Chronic Refractory Gout at EULAR 2019

Jun 12, 2019

Invitae Announces ID YOUR IRD Program to Expand Access to Genetic Testing for Inherited Retinal Disorders

Jun 12, 2019

Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines

Jun 12, 2019

Constellation Pharmaceuticals Presentation Highlights Enhanced EZH2 Target Engagement, Leading to Second-Generation EZH2 Inhibitor CPI-0209

Jun 11, 2019

Principia Biopharma Appoints Patrick Machado To Board of Directors

Jun 11, 2019

ReViral Appoints Alex C. Sapir as Chief Executive Officer

Jun 10, 2019

Aerpio Initiates Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma

Jun 7, 2019

Nerre Therapeutics Announces Positive Findings From Phase 2B Study With Orvepitant In Chronic Cough

Jun 5, 2019

HLS Therapeutics Announces Closing of $50 Million Bought Deal Offering

Jun 4, 2019

ObsEva SA Announces Completion of Patient Recruitment in IMPLANT 4 Phase 3 Clinical Trial of Nolasiban for Improving IVF Outcomes

Jun 4, 2019

Verona Pharma Initiates Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD

Jun 4, 2019

Prevail Therapeutics Announces IND Active for Phase 1/2 Trial of its Gene Therapy PR001 to Treat Parkinson’s Disease Patients with GBA1 Mutations

Jun 3, 2019

Alpine Immune Sciences Appoints Biopharma Veteran Wayne Gombotz as Chief Technology Officer

Jun 3, 2019

SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for the Treatment of a Severe Form of Neurofibromatosis Type 1

Jun 3, 2019

ARQ-151 Atopic Dermatitis P2a Trial Initiated

Jun 3, 2019

Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis Patients

Jun 3, 2019

TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage

Jun 3, 2019

Aeglea BioTherapeutics Doses First Patient in Pivotal Phase 3 PEACE Trial of Pegzilarginase in Arginase 1 Deficiency

Jun 3, 2019

Invitae introduces new service to make it easier for consumers to receive the medical genetic testing that experts trust

Jun 2, 2019

Corvus Pharmaceuticals Presents Initial CPI-006 Phase 1/1b Clinical Data at 2019 ASCO Annual Meeting

May 31, 2019

Turning Point Therapeutics Announces Updated Interim Clinical Data of Repotrectinib in Advanced ROS1+ Non-Small Cell Lung Cancer

May 31, 2019

Research from Invitae Demonstrates the Importance of Germline Multigene Panel Testing in Guiding Therapy for Expanding Groups of Cancer Patients

May 30, 2019

Ascendis Pharma A/S Reports First Quarter 2019 Financial Results

May 30, 2019

Passage Bio Announces Third Gene Therapy Development Program in Krabbe Disease and Supports Million Dreams Fundraising Gala

May 29, 2019

Audentes Therapeutics Announces Changes to Senior Management Team

May 29, 2019

Imara Announces FDA Fast Track Designation for IMR-687 for the Treatment of Sickle Cell Disease

May 29, 2019

Cyrus Biotechnology Integrates DNA/RNA support into its Rosetta-based Protein Design Platform

May 22, 2019

World's First MRIdian Center Treats 1,000th Patient with MRI-Guided Radiation Therapy

May 22, 2019

Synlogic Announces Clinical Collaboration to Evaluate SYNB1891 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors

May 22, 2019

Tyto Care Joins Epic App Orchard to Offer One-of-a-kind Integrated Telehealth Service to Patients and Health Providers

May 22, 2019

89bio Reports Positive Top-line Data from Phase 1 Single-Ascending Dose Clinical Trial of BIO89-100, an Investigational Medicine for NASH

May 21, 2019

BELLUS Health Presents Phase 1 Data for BLU-5937, its Lead Product Candidate for the Treatment of Refractory Chronic Cough, at the American Thoracic Society International Conference

May 21, 2019

Crinetics Pharmaceuticals Initiates Phase 1 Study Of CRN01941 For The Treatment Of Neuroendocrine Tumors

May 21, 2019

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline

May 20, 2019

Ascendis Pharma A/S Announces Preliminary Data from Single Arm Phase 3 fliGHt Trial Demonstrated TransCon™ hGH was Safe and Well-Tolerated in Pediatric Subjects Previously Treated with Daily Growth Hormone

May 20, 2019

SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors

May 20, 2019

Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at American Thoracic Society 2019 International Conference

May 20, 2019

Principia Presents Phase 1 Data Of Prn1371 In Patients With Metastatic Bladder Cancer

May 20, 2019

resTORbio Presents Additional Phase 2b Data at the American Thoracic Society International Conference for RTB101 as a Potential Immunotherapy to Reduce the Incidence of Respiratory Tract Infections in Patients 65 Years of Age and Older with Asthma

May 16, 2019

Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics

May 16, 2019

Constellation Pharmaceuticals Provides Interim Update of Data for CPI-0610 in ASCO and EHA Abstracts

May 16, 2019

Prevail Therapeutics Announces Executive Team Promotion and Appointments to Board of Directors

May 15, 2019

resTORbio Reports First Quarter 2019 Financial Results and Corporate Update

May 15, 2019

Turning Point Therapeutics Announces FDA Clearance Of Investigational New Drug Application For TPX-0022, A Novel MET/CSF1R/SRC Inhibitor

May 15, 2019

X4 Pharmaceuticals and The Leukemia & Lymphoma Society Announce Collaboration to Advance Development of Mavorixafor in Waldenström’s Macroglobulinemia

May 15, 2019

TigerConnect Names Sarah Shillington SVP of Client Success

May 15, 2019

Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products

May 14, 2019

ReViral to Present Data Showing Absence of Clinical Resistance in Volunteers Infected with RSV then Treated with Sisunatovir (RV521)

May 14, 2019

Principia Biopharma Announces First Patient Dosed In Sanofi’s Phase 2b Trial Of SAR442168 In Multiple Sclerosis, Triggering $30 Million Milestone

May 14, 2019

resTORbio Appoints Lloyd Klickstein, M.D., Ph.D., as Chief Scientific Officer

May 14, 2019

Turning Point Therapeutics Names Biotech Veteran Patrick Machado, J.D. To Its Board Of Directors.

May 13, 2019

Alector Reports Recent Business Highlights and First Quarter 2019 Financial Results

May 13, 2019

ORIC Pharmaceuticals Announces Initiation of Phase 1b Study with ORIC-101 in Patients with Cancer

May 13, 2019

Crinetics Pharmaceuticals Reports First Quarter 2019 Financial Results And Provides Corporate Update

May 10, 2019

Nabriva Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

May 9, 2019

ObsEva SA Announces Initiation of Phase 3 EDELWEISS 2 and 3 Trials of Linzagolix for Endometriosis Associated Pain in U.S., Canada and Europe

May 9, 2019

Kala Pharmaceuticals Reports First Quarter 2019 Financial Results

May 9, 2019

Harpoon Therapeutics Reports First Quarter 2019 Financial Results And Provides Corporate Update

May 9, 2019

ObsEva Reports First Quarter 2019 Financial Results

May 9, 2019

Avedro, Inc. Announces First Quarter 2019 Financial Results

May 9, 2019

NeuroPace Shares Positive Data from Studies of the RNS System at the American Academy of Neurology 2019 Annual Meeting

May 9, 2019

resTORbio Announces Initiation of Phase 3 Clinical Program of RTB101 in Clinically Symptomatic Respiratory Illness

May 9, 2019

Aerpio Reports First Quarter 2019 Financial Results and Provides Business Update

May 9, 2019

Acutus Medical Expands AFib Offerings; Announces Strategic Acquisition and New Partnerships in Monitoring and Therapy

May 9, 2019

Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2019 Financial Results

May 9, 2019

Synlogic Reports First Quarter 2019 Financial Results and Provides Business Update

May 9, 2019

Selecta Biosciences Reports First Quarter 2019 Financial Results and Provides Corporate Update

May 8, 2019

Nabriva Therapeutics Announces Submission of Marketing Authorization Application for Lefamulin to Treat Community-Acquired Pneumonia in Adults by European Medicines Agency

May 8, 2019

Adimab Announces Antibody Discovery Platform Transfer with Takeda

May 8, 2019

SI-BONE, Inc. Reports First Quarter 2019 Financial Results

May 8, 2019

Adimab Announces Multi-Target Expansion for the Discovery of Antibodies with Another Global Pharma Partner

May 8, 2019

BELLUS Health Provides Update on Its Chronic Cough Drug Candidate BLU-5937 and Reports Financial and Operating Results for the First Quarter Ended March 31, 2019

May 8, 2019

scPharmaceuticals Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

May 8, 2019

Adimab Expands Research Agreement with Regeneron

May 8, 2019

Constellation Pharmaceuticals Announces First-Quarter 2019 Financial Results

May 8, 2019

Tricida Announces First Quarter 2019 Financial Results

May 7, 2019

Xenon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update

May 7, 2019

Verona Pharma Initiates Additional Phase 2b Clinical Trial with Nebulized Ensifentrine to Inform Dose Selection for Phase 3 Trials

May 7, 2019

Aeglea BioTherapeutics Reports First Quarter 2019 Financial Results and Corporate Highlights

May 7, 2019

Principia Biopharma Reports First Quarter Financial Results

May 7, 2019

Signatera� Blood Test Detects Bladder Cancer Relapse Up to Eight Months Earlier Than Current Clinical Standards

May 7, 2019

Verona Pharma plc Operational Update and Financial Results for the Three Months Ended March 31, 2019

May 7, 2019

Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year

May 7, 2019

Peloton Therapeutics Appoints Timothy P. Coughlin and Thilo Schroeder, Ph.D. to its Board of Directors

May 7, 2019

Kyn Therapeutics Strengthens Leadership Team with Key Appointments

May 7, 2019

Audentes Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

May 7, 2019

Verrica Pharmaceuticals Reports First Quarter 2019 Financial Results

May 6, 2019

Significant Clinical Progress as Adaptimmune Announces Responses with ADP-A2M4 in Synovial Sarcoma and Antitumor Activity in Other Solid Tumors

May 6, 2019

Inspire Medical Systems, Inc. Announces Additional 11.2 Million Covered Lives with New Blue Cross Blue Shield Coverage Policies

May 6, 2019

Turning Point Therapeutics And Almac Diagnostic Services Announce Approval Of An Investigational Device Exemption For The Companion Diagnostic Assay To The Registrational TRIDENT-1 Clinical Study

May 6, 2019

Alector Announces First Alzheimer’s Disease Patient Dosed in Phase 1b Study of AL002

May 6, 2019

TransMedics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 6, 2019

Adaptimmune Reports First Quarter 2019 Financial Results

May 3, 2019

Rhythm Pharmaceuticals Reports First Quarter 2019 Financial Results

May 2, 2019

Aerpio Pharmaceuticals Presents Data Showing Potential of AKB-9778, a VE-PTP Inhibitor/Tie2 Activator, to Lower Intra-ocular Pressure in Human Subjects

May 2, 2019

ViewRay Reports First Quarter 2019 Results

May 2, 2019

CTI BioPharma Reports First Quarter 2019 Financial Results

May 2, 2019

Intellia Therapeutics Announces First Quarter 2019 Financial Results and Company Update

May 1, 2019

Audentes Therapeutics Presents New Positive Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 for X-linked Myotubular Myopathy, at 22nd Annual Meeting of the American Society of Gene and Cell Therapy

May 1, 2019

Avedro Completes Enrollment in Pivotal U.S. Phase 3 Epi-On Corneal Cross-Linking Clinical Trial for Progressive Keratoconus

May 1, 2019

Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results

Apr 30, 2019

Synlogic Presents Data Describing a Solid Oral Formulation Process for Synthetic Biotic™ aMedicine SYNB1618 for the Treatment of PKU at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Apr 30, 2019

Synthorx Reports First Quarter Financial Results

Apr 30, 2019

Adicet Bio Appoints Anil Singhal Chief Executive Officer

Apr 30, 2019

Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for Intravenous CONTEPO™ (fosfomycin) for injection

Apr 30, 2019

Arcutis, Inc. Announces Board of Directors

Apr 29, 2019

ObsEva SA Reports Further Infant Follow-up Data from IMPLANT2 Trial Echoing Favorable Safety Profile of Nolasiban in IVF

Apr 29, 2019

Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy

Apr 26, 2019

Acutus Medical’s New Contact Mapping Software Receives CE Mark

Apr 25, 2019

TELA Bio® Appoints Kurt Azarbarzin Chairman of Board of Directors

Apr 24, 2019

X4 Pharmaceuticals Appoints E. Lynne Kelley, M.D. as Chief Medical Officer

Apr 24, 2019

Ascendis Pharma A/S Announces Presentations Related to Rare Disease Endocrinology Pipeline at Upcoming Medical Conferences

Apr 23, 2019

Audentes Therapeutics Announces Launch of New State-of-the-Art Internal cGMP Plasmid Manufacturing Facility

Apr 22, 2019

Turning Point Therapeutics Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

Apr 18, 2019

TELA Bio® Announces 510(k) Clearance for Restella™ Reconstructive BioScaffolds for Reconstructive Surgery

Apr 18, 2019

Alpine Immune Science Appoints Stanford Peng to President and Head of Research and Development

Apr 18, 2019

ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada

Apr 18, 2019

Harpoon Therapeutics Doses First Patient with a Mesothelin-Targeting T Cell Engager (HPN536) in Phase 1/2A Clinical Trial for Ovarian and Other Solid Tumor Cancers

Apr 18, 2019

Principia Bipharma Appoints Shao-Lee Lin Md PhD to Board of Directors

Apr 17, 2019

Alector Announces First Frontotemporal Dementia Patient Dosed in Phase 1b Study of AL001

Apr 17, 2019

ViewRay Partners with Largest Independent Distributor in Australia and New Zealand to Bring Benefits of MRI-Guided Radiation Therapy to the Region

Apr 16, 2019

Turning Point Therapeutics Announces Pricing Of Initial Public Offering

Apr 16, 2019

Selecta Biosciences Presents New Preclinical Data from its Gene Therapy Program at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting

Apr 16, 2019

Inspire Medical Systems, Inc. Announces the 5,000th Patient to Receive Inspire Therapy

Apr 15, 2019

SI-BONE, Inc. Announces FDA Clearance of iFuse Bedrock™ Novel Spinopelvic Fixation Technology

Apr 12, 2019

X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants

Apr 11, 2019

ViewRay Announces Publication of Retrospective Study on MR-guided Radiation Treatment for Locally Advanced Pancreatic Cancer

Apr 11, 2019

Clementia Pharmaceuticals Inc. Announces Receipt of Final Court Approval for Plan of Arrangement With Ipsen S.A.

Apr 11, 2019

X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants

Apr 10, 2019

Imara Appoints Chief Financial & Chief Operating Officer

Apr 10, 2019

Realm Therapeutics Announces 2018 Annual Report Available and Form 20-F Filing

Apr 9, 2019

Synlogic Appoints Scott Plevy M.D. as Chief Scientific Officer

Apr 9, 2019

Verona Pharma Granted Key EU Patent Related to Late-stage COPD Clinical Candidate Ensifentrine

Apr 9, 2019

Clementia Pharmaceuticals Inc. Shareholders Approve Plan of Arrangement With Ipsen S.A.

Apr 9, 2019

Peloton Therapeutics Announces Completion of Enrollment in Phase 2 Trial of PT2977 for Treatment of von Hippel-Lindau Disease-associated Renal Cell Carcinoma

Apr 8, 2019

Audentes Therapeutics Announces Expansion of AAV Technology Platform and Pipeline with New Development Programs for Duchenne Muscular Dystrophy and Myotonic Dystrophy

Apr 8, 2019

Inspire Medical Systems, Inc. Announces Three New Positive Coverage Policies Issued by Blue Cross Blue Shield Plans

Apr 8, 2019

Turning Point Therapeutics Appoints Annette North As Executive Vice President And General Counsel

Apr 8, 2019

Tricida Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Apr 8, 2019

https://www.reviral.co.uk/news/45/48/ReViral-Announces-Grant-of-Key-US-Composition-of-Matter-Patent-For-Their-Respiratory-Syncytial-Virus-inhibitor-programme.html

Apr 7, 2019

Aeglea BioTherapeutics Announces New Positive Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 Annual Meeting of the Society for Inherited Metabolic Disorders

Apr 5, 2019

Avedro Reaches Reimbursement Milestone for Its FDA-Approved Procedure for Progressive Keratoconus

Apr 5, 2019

Realm Therapeutics Announces Receipt of Nasdaq Listing Determination and Requests Hearing

Apr 4, 2019

Grant of Options and RSUs and PDMR Dealings

Apr 3, 2019

BELLUS Health Announces Clearance of U.S. IND for BLU-5937 Phase 2 Study in Chronic Cough Patients

Apr 3, 2019

Sierra Reports Late-Breaking SRA141 Preclinical Data in Poster at AACR 2019

Apr 3, 2019

Sonendo® to Launch the GentleWave® System in Canada at AAE 2019

Apr 3, 2019

Ascendis Pharma A/S Reports Full Year 2018 Financial Results

Apr 3, 2019

Tricida Announces Pricing of Public Offering of Common Stock

Apr 2, 2019

ORIC Pharmaceuticals Presents Evidence of Glucocorticoid Receptor-Medicated Cancer Treatment Resistance at the AACR Annual Meeting

Apr 2, 2019

resTORbio Announces Initiation of Phase 1b/2a Trial of RTB101 in Parkinson’s Disease

Apr 2, 2019

Adaptimmune Presents Safety Data with Evidence of Tumor Necrosis in One Patient from ADP-A2AFP Study at American Association for Cancer Research (AACR) Meeting

Apr 2, 2019

X4 Pharmaceuticals Appoints Murray W. Stewart, M.D. to Board of Directors

Apr 1, 2019

Tricida Announces Proposed Public Offering of Common Stock

Apr 1, 2019

Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice President and Chief Financial Officer

Apr 1, 2019

Turning Point Therapeutics’ Kinase Inhibitors Show High Potency Against Targeted Oncogene Drivers And Their Mutations

Apr 1, 2019

Peloton Therapeutics Announces Clinical Data Update for PT2977 at European International Kidney Cancer Symposium

Apr 1, 2019

X4 Pharmaceuticals Provides Business and Clinical Development Update

Apr 1, 2019

Fusion Pharmaceuticals Raises $105 Million In Oversubscribed Series B Financing

Apr 1, 2019

SpringWorks Therapeutics Completes $125 Million Series B Financing

Apr 1, 2019

Adaptimmune Presents Preclinical Data for its Next Generation SPEAR T-cell Targeting MAGE-A4 at the American Association for Cancer Research (AACR) Annual Meeting

Apr 1, 2019

Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR Meeting

Apr 1, 2019

Alector Initiates Phase 1 Trial of AL003 for the Treatment of Patients with Alzheimer’s Disease

Apr 1, 2019

Sierra Reports Late-Breaking Preclinical Data for SRA737 Presented at AACR 2019

Apr 1, 2019

Happy April 1! Announcing Cyrus ROSVAC-4!

Mar 29, 2019

Selecta Biosciences Initiates Head-to-Head Clinical Trial (COMPARE) of SEL-212 vs. KRYSTEXXA® in Patients with Chronic Refractory Gout and Strengthens Management Team

Mar 28, 2019

Tricida Announces Positive Results From Long-Term Clinical Trial of TRC101 in Patients With CKD and Metabolic Acidosis

Mar 28, 2019

Tricida Announces Fourth Quarter and Full-Year 2018 Financial Results

Mar 28, 2019

Tricida Announces $200 Million Debt Facility With Hercules Capital

Mar 28, 2019

Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development

Mar 27, 2019

Imara Appoints Chief Medical Officer

Mar 26, 2019

Alector Reports Recent Business Highlights and Fourth Quarter and Full Year 2018 Financial Results

Mar 25, 2019

Turning Point Therapeutics Appoints Jim Mazzola to Lead Corporate Communication and Investor Relations

Mar 25, 2019

Ascendis Pharma Announces Results of Study at ENDO 2019 Evaluating Impact of Hypoparathyroidism on Patient Quality-of-Life

Mar 24, 2019

Ascendis Pharma Announces Phase 3 heiGHt Trial Demonstrated Superior Efficacy and Comparable Safety and Tolerability of TransCon™ hGH to a Daily Growth Hormone

Mar 22, 2019

resTORbio, Inc. Announces Closing Public Offering of Common Stock

Mar 22, 2019

2018 Annual Report and Accounts and Notice of AGM

Mar 21, 2019

Turning Point Therapeutics Files Registration Statement for Proposed Initial Public Offering

Mar 21, 2019

Sonendo® Announces Three Key Hires

Mar 21, 2019

Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director

Mar 21, 2019

scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2018 Financial Results and Provides Business Update

Mar 21, 2019

Avedro, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Full Year 2019 Financial Outlook

Mar 19, 2019

Crinetics Pharmaceuticals Doses First Patients in Phase 2 Clinical Trials of CRN00808 for Acromegaly

Mar 19, 2019

Principia Biopharma Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 18, 2019

Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2018 Financial Results

Mar 18, 2019

Imara Closes a $63MM Series B Cross-Over Financing

Mar 18, 2019

resTORbio Announces Positive End-of-Phase 2 Meeting with FDA and Planned Initiation of Global Phase 3 Program for RTB101

Mar 18, 2019

Crinetics Pharmaceuticals Appoints Gina Ford, RPH, MBA, as Vice President, Corporate Strategy and Commercial Planning

Mar 18, 2019

resTORbio Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 18, 2019

Aerpio Pharmaceuticals Announces Results From TIME-2b Study of AKB-9778 in Diabetic Retinopathy

Mar 17, 2019

Prevail Therapeutics Secures $50 Million in Series B Financing to Advance Pipeline of Gene Therapies for Neurodegenerative Diseases

Mar 15, 2019

Selecta Biosciences Announces Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update

Mar 15, 2019

Stereotaxis and Acutus Medical Combine Robotic Precision and High-Resolution Imaging to Treat Arrhythmias in First Integrated Procedures

Mar 14, 2019

Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2018 Financial Results

Mar 14, 2019

ViewRay Reports Fourth Quarter and Full Year 2018 Results

Mar 14, 2019

Harpoon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

Mar 14, 2019

Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO2019

Mar 13, 2019

ObsEva SA to Present OBE022 Clinical Data for Treatment of Pre-term labor (PTL) at the SRI 66th Annual Scientific Meeting, March 12 -16, 2019

Mar 13, 2019

Avedro, Inc. Announces Appointment of Patrick B. Jacques as Vice President of Sales

Mar 13, 2019

Crinetics Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results And Provides Corporate Update

Mar 13, 2019

CTI BioPharma Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Highlights

Mar 13, 2019

X4 Pharmaceuticals Completes Merger with Arsanis

Mar 12, 2019

Nabriva Therapeutics Reports 2018 Financial Results and Recent Corporate Highlights

Mar 12, 2019

Synlogic Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Mar 11, 2019

Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 11, 2019

Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program

Mar 11, 2019

TELA Bio® Announces Multiple Presentations at American Hernia Society Annual Meeting in Las Vegas

Mar 11, 2019

Marinus Pharmaceuticals Provides Business Update and 2018 Financial Results

Mar 11, 2019

Tricida Announces Publication of Positive TRC101 Pivotal Trial Results in The Lancet

Mar 8, 2019

Sublimity Therapeutics to Present Positive Data for Ulcerative Colitis Drug Candidate

Mar 8, 2019

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 7, 2019

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 7, 2019

Verrica Reports Fourth Quarter and Full Year 2018 Financial Results

Mar 7, 2019

Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Mar 7, 2019

Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights

Mar 6, 2019

Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock

Mar 6, 2019

Xenon Pharmaceuticals Reports 2018 Financial Results and Provides Corporate Update

Mar 6, 2019

SI-BONE, Inc. Announces Journal of Bone and Joint Surgery (JBJS) Publishes 2-Year Results from iMIA, a European Multicenter Randomized Controlled Trial (RCT) of SI Joint Fusion with iFuse Implant System® vs Conservative Care

Mar 6, 2019

Synlogic Announces Achievement of Milestone in Collaboration to Develop Synthetic Biotic™ Medicines to Treat Inflammatory Bowel Disease

Mar 6, 2019

Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy

Mar 5, 2019

ObsEva Reports Fourth Quarter and Full Year 2018 Financial Results, Provides Business Update

Mar 5, 2019

Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

Mar 5, 2019

Aerpio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update

Mar 5, 2019

Cyrus Biotechnology Announces Release of Antibody Structure Prediction Software for Biologics Drug Development and Discovery

Mar 4, 2019

Verona Pharma Reports Positive Interim Data with Ensifentrine Dry Powder Inhaler Formulation in First of Two-Part Phase 2 Clinical Trial in COPD

Mar 4, 2019

Inspire Medical Systems, Inc. Announces Five New Positive Coverage Policies Issued by Blue Cross Blue Shield Plans

Mar 4, 2019

Invitae Announces Proposed Public Offering of Common Stock

Mar 4, 2019

NextCure and Yale Publish Nature Medicine Paper Detailing Novel Immunomedicine Target Siglec-15

Mar 4, 2019

Constellation Pharmaceuticals Appoints Jessica Christo as Chief Product Development Officer

Mar 4, 2019

ORIC Pharmaceuticals Appoints Edna Chow Maneval, PhD, as Senior Vice President of Clinical Development

Mar 4, 2019

Ascendis Pharma Announces Once-weekly TransCon™ Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency

Mar 4, 2019

Fusion Pharmaceuticals Announces Appointment Of John J. Crowley As Chief Financial Officer

Mar 2, 2019

Verrica Pharmaceuticals Presents Positive Results from Two Phase 3 Clinical Trials of VP-102 in Late-Breaking Oral Presentation at the 2019 American Academy of Dermatology Meeting

Mar 2, 2019

Principia Biopharma Announces Positive Data From Phase 2 Pemphigus Vulgaris Trial At 2019 American Academy Of Dermatology Annual Meeting In Late-Breaking Presentation

Mar 1, 2019

Principia Biopharma Presents Phase 1 Clinical Data From CNS Penetrating BTK Inhibitor Candidate PRN2246/SAR442168 at ACTRIMS 2019

Feb 28, 2019

Audentes Therapeutics Recognizes Rare Disease Day by Launching """"Be Bold for Courageous Patients"""" Program to Support Patients Living with Rare Diseases

Feb 28, 2019

Sierra Oncology Reports 2018 Year End Results

Feb 28, 2019

Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon CNP as Treatment for Achondroplasia

Feb 27, 2019

Audentes Therapeutics Reports Fourth Quarter 2018 and Full Year Financial Results and Provides Corporate Update

Feb 27, 2019

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results

Feb 27, 2019

Sierra Oncology Announces Late-Breaking Oral and Poster Presentations at AACR 2019 for SRA737 and SRA141 Preclinical Data

Feb 27, 2019

CORRECTING and REPLACING -- Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update

Feb 26, 2019

ReViral Ltd Appoints Seth Hetherington as Chief Medical Officer as it Prepares its Lead RSV Candidate to Enter Pediatric Phase IIa Clinical Trials

Feb 26, 2019

Verona Pharma Reports Financial Results for Full Year Ended December 31, 2018 and Provides Clinical Development Update

Feb 26, 2019

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results

Feb 26, 2019

Marinus Announces Leadership Transition

Feb 25, 2019

Ipsen to Acquire Clementia Pharmaceuticals to Significantly Boost Rare Disease Portfolio

Feb 22, 2019

Kala Pharmaceuticals Reports Inducement Grand Under NASDAQ Listing Rule 5635©(4)

Feb 21, 2019

ViewRay Announces FDA 510(k) Clearance for Advancements in MRI and Functional Imaging Technologies for MRIdian MRI-Guided Radiation Therapy System

Feb 21, 2019

BELLUS Health Presents 2018 Highlights and 2019 Corporate Plan

Feb 20, 2019

Peloton Therapeutics Secures $150 Million in Series E Financing

Feb 20, 2019

Constellation Pharmaceuticals Announces Appointment to Board of Directors

Feb 19, 2019

Alpine Immune Sciences Presents Preclinical ALPN-101 GvHD Data at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR (TCT Meetings)

Feb 19, 2019

Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults

Feb 19, 2019

Invitae More Than Doubles Annual Volume and Revenue Year-Over-Year, Delivering 117% in Revenue Growth Driven by 102% Growth in Volume in 2018

Feb 19, 2019

Modis Therapeutics Announces that MT1621 Receives Breakthrough Therapy Designation from FDA For the Treatment of TK2 Deficiency

Feb 13, 2019

Avedro Announces Pricing of Initial Public Offering

Feb 12, 2019

Synlogic Appoints Patricia N. Hurter, Ph.D. to Board of Directors

Feb 12, 2019

Invitae Launches Non-Invasive Prenatal Screening (NIPS), Offering In-Depth Genetic Information in Early Pregnancy

Feb 12, 2019

NeuroPace Announces New Category I CPT Code from AMA for Electrocorticography from an Implanted Brain Neurostimulator

Feb 11, 2019

Alpine Immune Sciences Announces First Subjects Dosed in Phase I Clinical Trial for Lead Autoimmune/Inflammatory Disease Program ALPN-101

Feb 11, 2019

Clementia Granted Rare Pediatric Disease Designation by FDA for Palovarotene for Fibrodysplasia Ossificans Progressiva

Feb 11, 2019

CTI BioPharma Receives $10 Million Milestone Payment for TRISENOX®

Feb 11, 2019

Ascendis Pharma Initiates Global Phase 2 Trial for TransCon PTH in Adult Subjects with Hypoparathyroidism

Feb 7, 2019

Health Catalyst Secures up to $100 Million with Financing Led By OrbiMed

Feb 7, 2019

Harpoon Therapeutics Announces Pricing of Initial Public Offering

Feb 7, 2019

Sublimity Therapeutics Presents Encouraging New Efficacy Data at the 2019 Crohn's & Colitis Congress

Feb 7, 2019

Alector Announces Pricing of Initial Public Offering

Feb 6, 2019

HLS Therapeutics Announces Graduation to the Toronto Stock Exchange

Feb 6, 2019

resTORbio Appoints Erkan Baloglu, Ph.D., M.B.A., as Vice President of Drug Discovery and Medicinal Chemistry

Feb 6, 2019

Aeglea BioTherapeutics Announces Pricing of $60.0 Million Public Offering

Feb 6, 2019

Corvus Presents Updated Biomarker and Clinical Results from Lead Pipeline Programs�CPI-444 and CPI-006 at Immuno-Oncology 360� Conference

Feb 5, 2019

Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock

Feb 5, 2019

Graybug Vision Appoints Frédéric Guerard as Chief Executive Officer Pharmaceutical Industry Veteran and Former Worldwide Business Franchise Head of Ophthalmology at Novartis

Feb 5, 2019

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 4, 2019

SI-BONE, Inc. Announces Additional Exclusive Coverage Policies for iFuse

Feb 4, 2019

Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer

Feb 4, 2019

Avedro Launches Initial Public Offering

Feb 1, 2019

CTI BioPharma Receives Results of the CHMP Oral Explanation for Pacritinib in the Treatment of Myelofibrosis and Provides Development Update

Jan 31, 2019

Audentes Therapeutics Announces Next Steps in the Development of AT132 to Treat XLMTM Following Collaborative Initial Meeting with FDA Under RMAT Designation

Jan 29, 2019

scPharmaceuticals Inc. Announces Development Agreement with West Pharmaceutical Services for Next-Generation FUROSCIX� On-Body Infusor

Jan 28, 2019

Xenon Provides Key Regulatory Updates on XEN007 and XEN1101

Jan 28, 2019

Corvus Pharmaceuticals Announces Appointment of New Member of Board of Directors and Hiring of Chief Medical Officer

Jan 24, 2019

TELA Bio Announces First Patient in Europe Treated with OviTex® Reinforced BioScaffolds

Jan 24, 2019

Intellia Therapeutics Names Fred Cohen, M.D., to Board of Directors

Jan 23, 2019

Selecta Biosciences Announces Pricing of Public Offering of Common Stock

Jan 23, 2019

ObsEva SA Reports Initial Good Safety of OBE022 in Pregnant Women with Preterm Labour and Announces Start of Part B of the PROLONG Trial

Jan 22, 2019

Selecta Biosciences Announces Proposed Public Offering of Common Stock

Jan 22, 2019

World's First MRIdian Center Celebrates Five Years of MRI-Guided Radiation Treatments

Jan 21, 2019

Graybug Vision Presents Top Line Results of Phase 1/2a ADAGIO Study at Hawaiian Eye & Retina 2019

Jan 18, 2019

Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies

Jan 18, 2019

Kala Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635C(4)

Jan 17, 2019

Terns Pharmaceuticals Announces the Appointment of Erin Quirk, M.D., as Chief Medical Officer

Jan 17, 2019

Tricida Announces Hiring of Susannah Cantrell, Ph.D., as Chief Commercial Officer

Jan 17, 2019

Promentis Pharmaceuticals Announces Commencement of Phase 2 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

Jan 17, 2019

Proteus Digital Health® Launches Digital Oncology Medicines to Improve Patient Outcomes

Jan 17, 2019

Aerpio Pharmaceuticals Announces Completion of Patient Dosing in TIME-2b Study of AKB-9778 in Diabetic Retinopathy

Jan 16, 2019

Alpine Immune Sciences Announces $25 Million Private Placement

Jan 16, 2019

Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia

Jan 16, 2019

Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Horizon Blue Cross Blue Shield of New Jersey

Jan 14, 2019

Nabriva Therapeutics Provides Update on PDUFA Date for Intravenous CONTEPO™

Jan 14, 2019

Inspire Medical Systems, Inc. Announces First BCBS Coverage Policy following Evidence Street’s Positive Therapy Indication Summary

Jan 14, 2019

Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance Treatment

Jan 10, 2019

TELA Bio begins commercialization for Large Size OviTex® Reinforced BioScaffolds for Hernia Repair and Abdominal Wall Reconstruction after Aroa Biosurgery receives 510k clearance.

Jan 10, 2019

Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas

Jan 9, 2019

Adimab Provides 2018 Update on Clinical Pipeline

Jan 9, 2019

Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554

Jan 9, 2019

Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

Jan 8, 2019

Adimab Provides Year-End Update on 2018 Partnership Activities

Jan 8, 2019

Corvus Announces Enrollment in Second Arm of Phase 1/1b Dose-Escalation Trial of Anti-CD73 Antibody, CPI-006, Focused on Combination with CPI-444 Adenosine Antagonist

Jan 8, 2019

Dr. Mary Kerr CEO NeRRe Therapeutics Presents at the Biotech Showcase, San Francisco

Jan 7, 2019

Ascendis Pharma A/S Introduces Vision 3x3: A Strategic Roadmap Through 2025 to Achieve Sustainable Growth Using Multiple Approaches

Jan 7, 2019

Sublimity Therapeutics Receives Investigational New Drug (IND) Clearance from U.S. Food and Drug Administration (FDA)

Jan 7, 2019

Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Horizon Blue Cross Blue Shield of New Jersey

Jan 7, 2019

Cyrus Bio announces full release of rapid and accurate protein mutational free energy tool in Cyrus Bench

Jan 7, 2019

ViewRay Announces Preliminary Fourth Quarter and Fiscal Year 2018 Results

Jan 7, 2019

Audentes Therapeutics Reports on Recent Progress and Outlines 2019 Key Priorities

Jan 7, 2019

KaNDy Therapeutics Announces the Appointmetn of Andrew Kay as Independent Chairman of the Board

Jan 7, 2019

Kala Pharmaceuticals Announces the Launch of Inveltys and the Hiring of a Specialty Ophthalmology Sales Organization

Jan 7, 2019

Adimab Partner Innovent Receives Product Approval for PD-1 Antibody for Hodgkin's Lymphoma

Jan 7, 2019

Verrica Appoints Neil D. DeHenes as Vice President of Distribution, Trade and Channel Strategy

Jan 7, 2019

SI-BONE Reports Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2018

Jan 7, 2019

Dose Escalation in Liver Cancer Study with ADP-A2AFP (AFP) SPEAR T-cells and Moving to Expansion Phase in ADP-A2M10 (MAGE-A10) Lung Cancer Study after Favorable Safety Reviews

Jan 7, 2019

Invitae reports 2018 preliminary financial results, delivering more than 100% volume and revenue growth in 2018; projects sustained growth in expanding markets through 2019 and beyond

Jan 7, 2019

Gemini Therapeutics Announces the Initiation of CLARITY, a Disease Registry and Natural History Study of Subjects with Dry AMD and High-Risk Genotypes

Jan 6, 2019

Xenon Pharmaceuticals Outlines 2019 Key Milestones

Jan 4, 2019

Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 4, 2019

ViewRay Announces First Patient Enrolled in Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) Trial for Locally Advanced Pancreatic Cancer

Jan 4, 2019

Nabriva Therapeutics Provides Update on PDUFA Date for Intravenous CONTEPO™

Jan 3, 2019

Constellation Pharmaceuticals Provides Update on MANIFEST Clinical Trial of CPI-0610 in Myelofibrosis, Reviews 2018 Accomplishments, and Announces 2019 Data Disclosure Plans for Lead Programs

Jan 3, 2019

Selecta Biosciences Expands Potential for ImmTOR™ Platform and Streamlined Structure Under Leadership of New CEO, Carsten Brunn, Ph.D.

Jan 3, 2019

Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts

Jan 3, 2019

Verrica Achieves Positive Topline Results from Two Pivotal Phase 3 Clinical Trials of VP-102 in Patients with Molluscum Contagiosum

Jan 3, 2019

Audentes Therapeutics Appoints Eric B. Mosbrooker as Senior Vice President and Chief Commercial Officer

Jan 3, 2019

E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer

Jan 3, 2019

Verona Pharma Appoints Kathleen Rickard, MD, as Chief Medical Officer to Lead Late Stage Clinical Development of RPL554

Jan 2, 2019

Harpoon Therapeutics Announces Preliminary Safety and Pharmacology Data From Its HPN424 Phase 1 Trial in Prostate Cancer

Jan 2, 2019

Nora Brennan Joins TELA Bio® as Chief Financial Officer

Dec 20, 2018

Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults

Dec 19, 2018

resTORbio Appoints William Marshall, M.D., as Vice President of Medical Sciences

Dec 19, 2018

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635C(4)

Dec 19, 2018

Kyn Therapeutics Announces Initiation of Phase 1b/2 Clinical Studies of ARY-007 in Collaboration with Merck

Dec 18, 2018

CTI BioPharma Provides Program Update Following Regulatory Feedback from the U.S. FDA on Pacritinib Development

Dec 18, 2018

BELLUS Health Closes $35M Financing to Support Development of its Lead Drug Candidate BLU-5937 for Chronic Cough

Dec 17, 2018

Turning Point Therapeutics Mourns the Death of Board Member Lewis Shuster

Dec 17, 2018

Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD

Dec 17, 2018

Principia Biopharma Issues Statement About the Passing of Board Member Lewis J. Shuster

Dec 17, 2018

Inspire Medical Systems, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

Dec 13, 2018

Rhythm Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes

Dec 13, 2018

CTI BioPharma Announces Restructuring Plan

Dec 12, 2018

Singulex receives new, broad patent for highly sensitive methods for analysis of troponin

Dec 12, 2018

Adaptimmune Announces that Gwen Binder will leave in January 2019

Dec 12, 2018

Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines

Dec 12, 2018

Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Dec 11, 2018

Anthem Blue Cross Blue Shield Joins List of 60 Commercial Plans Covering Avedro's FDA-Approved Corneal Cross-Linking Procedure

Dec 11, 2018

Marinus Pharmaceuticals Announces Public Offering of Common Stock

Dec 11, 2018

BELLUS Health Announces Pricing of $35 Million Public Offering of Common Shares

Dec 11, 2018

Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency

Dec 11, 2018

KaNDy Therapeutics Announces Initiation of Phase 2B Trial of NT-814 For the Treatment of Troublesome Post-Menopausal Symptoms

Dec 10, 2018

BELLUS Health Announces Overnight Marketed Equity Offering

Dec 10, 2018

Constellation Pharmaceuticals Initiates Phase 2 Portion of ProSTAR Clinical Trial in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Dec 10, 2018

Marinus Pharmaceuticals Announces Positive Ganaxolone Data in Women With Postpartum Depression

Dec 7, 2018

Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dec 7, 2018

ObsEva R&D Day Showcases Multiple Women’s Health Programs and Outlines Plans for Transition to Commercial Operations

Dec 6, 2018

SI-BONE, Inc. Announces Blue Cross Blue Shield of Arizona (BCBS AZ) Establishes Positive Coverage for MIS SI Joint Fusion Exclusively with the Triangular Titanium iFuse Implant System

Dec 6, 2018

Intellia Therapeutics and Novartis Expand Cell Therapy Collaboration to Pursue CRISPR/Cas9-based Genome Editing in Additional Stem Cell Population

Dec 6, 2018

Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock

Dec 5, 2018

ReViral Board member Raymond Schinazi decorated with French Legion of Honour

Dec 5, 2018

Prevail Therapeutics Announces Executive Leadership Appointments

Dec 4, 2018

Marinus Pharmaceuticals Phase 2 Clinical Trial Data Show Long-term Effectiveness of Ganaxolone in Reducing Seizure Frequency in CDKL5 Deficiency Disorder Patients

Dec 4, 2018

Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock

Dec 3, 2018

Sierra Oncology Reports Robust Transfusion Independence Rates in Transfusion Dependent Myelofibrosis Patients Treated with Momelotinib

Dec 3, 2018

Xenon Announces Final Results of XEN1101 Phase 1 Clinical Trial and Update on XEN901 Phase 1 Clinical Trial at the American Epilepsy Society (AES) Annual Meeting

Dec 3, 2018

Selecta Biosciences Announces New Employment Inducement Grants

Dec 2, 2018

Harpoon Therapeutics Presents Preclinical Data Supporting Development of HPN217, A New BCMA-Targeting TRITAC, at the 2018 American Society of Hematology (ASH) Annual Meeting

Dec 2, 2018

NeuroPace Announces Final Results from the Largest Prospective Clinical Study in the Field of Neuromodulation with 9-Year Follow-Up at the 2018 American Epilepsy Society Annual Meeting

Nov 30, 2018

Clementia Announces the Departure of Chief Commercial Officer

Nov 30, 2018

Inspire Medical Systems, Inc. Announces Publication of Data From ADHERE Registry

Nov 29, 2018

Sierra Oncology Reports Preclinical Efficacy for Immunotherapy Combination with its Chk1 inhibitor SRA737

Nov 29, 2018

Constellation Pharmaceuticals Appoints Patrick Trojer, Ph.D., as Chief Scientific Officer

Nov 29, 2018

SI-BONE, Inc. Reports Third Quarter 2018 Financial Results

Nov 29, 2018

Realm Therapeutics Provides Update on Strategic Review

Nov 29, 2018

Principia Biopharma Reports Positive PRN1008 Phase 2 Top-Line Results And Initiates Phase 3 Pemphigus Program

Nov 28, 2018

ObsEva SA Announces Initiation of Phase 3 IMPLANT 4 Trial of Nolasiban in Europe, Canada and Russia for Improving IVF Outcomes

Nov 28, 2018

Ascendis Pharma A/S Reports Third Quarter 2018 Financial Results

Nov 28, 2018

Turning Point Therapeutics Appoints Jacob Chacko, M.D., to its Board of Directors

Nov 28, 2018

Ascendis Pharma A/S Announces Positive Preliminary Phase 1 Data for TransCon CNP

Nov 27, 2018

Arsanis and X4 Pharmaceuticals Agree to Merger

Nov 26, 2018

ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer

Nov 26, 2018

CTI BioPharma Provides Program Update Following Regulatory Feedback on Pacritinib Development from the European Medicines Agency

Nov 26, 2018

FDA Approves Vitrakvi® (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion(1,2)

Nov 23, 2018

Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635C(4)

Nov 21, 2018

Rob Fuchs joins ViewRay as Chief Human Resources Officer

Nov 20, 2018

Permanent J Code Issued for Avedro's Photrexa® Drug Formulations

Nov 19, 2018

BELLUS Health Announces Positive Top-Line Phase 1 Results for its Chronic Cough Drug Candidate BLU-5937

Nov 16, 2018

Alector Strengthens Board of Directors with Appointments of David Wehner, Richard Scheller and Louis Lavigne

Nov 16, 2018

Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

Nov 15, 2018

Alector Initiates Phase 1 Trial of AL002 for the Treatment of Patients with Alzheimer’s Disease

Nov 15, 2018

Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical Conference

Nov 15, 2018

Sierra Oncology Reports Preclinical Efficacy for Chk1 inhibitor SRA737 in Treatment Refractory Ovarian Cancer Models at the EORTC-NCI-AACR Symposium

Nov 15, 2018

Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018

Nov 14, 2018

Ascendis Pharma A/S Announces Third Quarter 2018 Financial Results and Business Update Conference Call on November 28

Nov 14, 2018

Attenua Announces First Patient Treated in Phase 2 Clinical Trial in Chronic Cough with Bradanicline

Nov 13, 2018

Synlogic Reports Third Quarter 2018 Financial Results and Provides Program Updates

Nov 13, 2018

resTORbio Reports Third Quarter 2018 Financial Results

Nov 13, 2018

scPharmaceuticals Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update

Nov 13, 2018

Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Nov 13, 2018

NextCure Raises $93 Million in Series B Financing — Proceeds Will Advance Growing Portfolio of Novel Immunomedicine Drug Candidates

Nov 13, 2018

Sierra Oncology Reports SRA141 Preclinical Efficacy at EORTC-NCI-AACR Symposium

Nov 13, 2018

Modis Therapeutics Announces PRIME Designation Granted by the European Medicines Agency to MT1621 for the Treatment of TK2 Deficiency

Nov 12, 2018

Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

Nov 11, 2018

Harpoon Therapeutics Announces Closing of $70M Series C Financing

Nov 10, 2018

Corvus Pharmaceuticals Announces Updated Results from Ongoing Clinical Studies of Lead Programs, CPI-444 and CPI-006, at SITC 33rd Annual Meeting

Nov 9, 2018

Arsanis Reports Financial Results for Third Quarter 2018

Nov 9, 2018

Alpine Immue Sciences Advances Oncology Programs with New ALPN-202 Preclinical Data and Key Additions to Scientific Advisory Board

Nov 9, 2018

Harpoon Therapeutics Unveils ProTriTAC Platform: A Novel, Protease-Activated T Cell Engager Platform Designed to Access a Broad Landscape of Solid Tumor Targets

Nov 9, 2018

Synthorx to Present Preclinical Data for THOR-707, a “Not-Alpha” IL-2 Synthorin, for the Treatment of Solid Tumors at SITC 2018

Nov 9, 2018

Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results

Nov 8, 2018

Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China

Nov 8, 2018

Loxo Oncology Reports Third Quarter 2018 Financial Results

Nov 8, 2018

Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results

Nov 8, 2018

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

Nov 8, 2018

Tricida Announces Third Quarter 2018 Financial Results

Nov 8, 2018

ViewRay Reports Third Quarter 2018 Results

Nov 8, 2018

Selecta Biosciences Announces Third Quarter 2018 Financial Results and Provides Corporate Update

Nov 8, 2018

Sierra Oncology Reports Third Quarter Results

Nov 8, 2018

Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2018 Financial Results

Nov 8, 2018

Aeglea BioTherapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

Nov 8, 2018

Alpine Immue Sciences Provides Corporate Update and Reports Third Quarter 2018 Financial Results

Nov 8, 2018

resTORbio Co-Founder and Chief Medical Officer Joan Mannick, M.D., to Present on TORC1 Inhibition at The Gerontological Society of America 2018 Annual Scientific Meeting

Nov 7, 2018

Invitae Reports 106% Annual Revenue Growth Driven by 95% Annual Growth in Volume in Third Quarter 2018

Nov 7, 2018

Waljit Dhillo, Professor in Endocrinology & Metabolism, Consultant Endocrinologist and an NIHR Research Professor at Imperial College London has joined KaNDy Therapeutics as a Scientific and Clinical Advisor

Nov 7, 2018

Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Nov 7, 2018

Clementia Reports Third Quarter 2018 Operating Results and Pipeline Updates

Nov 7, 2018

Verrica Pharmaceuticals Reports Third Quarter 2018 Financial Results

Nov 7, 2018

SpringWorks Therapeutics Receives FDA Fast Track Designation for Nirogacestat for the Treatment of Adult Patients with Desmoid Tumors

Nov 7, 2018

Aerpio Reports Third Quarter 2018 Financial Results and Provides Business Update

Nov 6, 2018

Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

Nov 6, 2018

Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update

Nov 6, 2018

Audentes Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Nov 6, 2018

Principia Biopharma Reports Third Quarter Financial Results

Nov 6, 2018

TELA Bio® Appoints Kurt Azarbarzin to Board of Directors

Nov 6, 2018

Nabriva Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

Nov 6, 2018

Xenon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Nov 6, 2018

ENYO Pharma announces the successful completion of phase Ib with its FXR agonist EYP001 and the start of phase II studies in two indications, NASH and HBV

Nov 6, 2018

resTORbio Appoints Michael Grissinger to its Board of Directors

Nov 6, 2018

Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2018

Nov 5, 2018

Lilly and NextCure Announce Collaboration to Discover and Develop Novel Immuno-Oncology Medicines

Nov 5, 2018

Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman

Nov 5, 2018

SpringWorks Therapeutics Receives FDA Orphan Drug Designation for MEK Inhibitor (PD-0325901) for the Treatment of Neurofibromatosis Type 1

Nov 1, 2018

Corvus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

Nov 1, 2018

Constellation Pharmaceuticals Receives FDA Fast Track Designation for CPI-0610 in Treatment of Myelofibrosis

Nov 1, 2018

Nabriva Therapeutics Completes Submission of New Drug Application to U.S. Food and Drug Administration for Intravenous CONTEPO™ to Treat Complicated Urinary Tract Infections

Nov 1, 2018

CTI BioPharma Reports Third Quarter 2018 Financial Results

Oct 31, 2018

Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment

Oct 31, 2018

BELLUS Health Announces Issuance of New U.S. Patent Claiming P2X3 Selectivity as a Means of Minimizing Taste Effects for its Lead Chronic Cough Drug Candidate BLU-5937

Oct 31, 2018

Intellia Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Developments

Oct 30, 2018

Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer

Oct 30, 2018

Cyrus Biotechnology and OpenEye Scientific Software Announce Collaboration and Cheminformatics Integration to Expedite New Drug Design and Development with Cyrus Bench Platform

Oct 29, 2018

Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria

Oct 29, 2018

Intellia Therapeutics Names Glenn Goddard as New Chief Financial Officer

Oct 29, 2018

Marinus Pharmaceuticals Provides Business Update and Third Quarter 2018 Financial Results

Oct 29, 2018

Modis Therapeutics Announces Appointment of Matthew R. Patterson to Board of Directors

Oct 29, 2018

ViewRay signs agreement with GenesisCare to bring the first MRIdian MRI-guided radiotherapy systems to the UK

Oct 29, 2018

Clementia Announces Pricing of Public Offering of Common Shares

Oct 26, 2018

Aeglea BioTherapeutics to Present Preclinical Data on a New Pipeline Therapeutic for Cystinuria in an Oral Presentation at the 2018 American Society of Nephrology (ASN) Annual Meeting

Oct 26, 2018

Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference

Oct 25, 2018

Aerpio Pharmaceuticals Announces Presentation of Renal Function Data from TIME-2 Study of AKB-9778 in Diabetic Retinopathy Patients at American Society of Nephrology Kidney Week 2018

Oct 25, 2018

Kala Pharmaceuticals Appoints Steven Zhang as Vice President of Medical Affairs

Oct 25, 2018

Pieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of Directors

Oct 24, 2018

PRINCIPIA BIOPHARMA APPOINTS DOLCA THOMAS, M.D. AS CHIEF MEDICAL OFFICER

Oct 24, 2018

TP Therapeutics and Almac Diagnostic Services Enter into Agreement to Develop Next-Generation Sequencing Pan-Cancer Companion Diagnostic

Oct 23, 2018

Clementia Announces Plan to Submit a New Drug Application for Palovarotene for the Treatment of FOP Based on Positive Phase 2 Results

Oct 23, 2018

NextCure Initiates Clinical Development for NC318, a Siglec-15 Targeting Antibody, for Solid Tumors

Oct 23, 2018

Selecta Biosciences Presents New Interim Data from Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at ACR 2018

Oct 22, 2018

Real-Time Adaptive Radiotherapy Capabilities of ViewRay's MRIdian Highlighted at Investor & Analyst Meeting at ASTRO 2018

Oct 22, 2018

Alpine Immune Sciences' Lead Program ALPN-101 Demonstrates Preclinical Activity in Inflammatory Arthritis and Neurological Inflammation

Oct 22, 2018

Aeglea BioTherapeutics Announces Positive Interim Clinical Data for Pegzilarginase in Advanced Melanoma Patients at the European Society for Medical Oncology 2018 Congress

Oct 22, 2018

Corvus Pharmaceuticals Announces New Data on Adenosine Gene Signature Biomarker Associated with Patient Response to CPI-444 at European Society for Medical Oncology (ESMO) 2018 Congress

Oct 21, 2018

Loxo Oncology Announces Larotrectinib Clinical Update in Patients with TRK Fusion Cancers at the European Society for Medical Oncology 2018 Congress

Oct 20, 2018

Updated Data from Ongoing MAGE-A10 and MAGE-A4 Studies Presented at the 2018 ESMO Congress

Oct 19, 2018

SI-BONE Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares

Oct 19, 2018

PRINCIPIA BIOPHARMA ANNOUNCES PRN1008 RECEIVES ORPHAN-DRUG DESIGNATION FROM FDA FOR TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA

Oct 19, 2018

TP Therapeutics Completes $80 Million Mezzanine Financing Co-Led by Foresite Capital and venBio Partners

Oct 18, 2018

Intellia Therapeutics Presents New Data in In Vivo and Ex Vivo Programs at the 26th Annual Congress of the European Society of Gene and Cell Therapy

Oct 18, 2018

Sonendo® and TDO® Software Expand Their Strategic Partnership

Oct 18, 2018

scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX

Oct 17, 2018

Inspire Medical Systems, Inc. Announces Presentation of Clinical Efficacy Data for Inspire Therapy for Treatment of Obstructive Sleep Apnea at Annual ENT Surgeon Conference

Oct 17, 2018

Aeglea BioTherapeutics Announces New Positive Interim Clinical Data and Improvements in Disease Manifestations for Ongoing Phase 1/2 Trial of Pegzilarginase in Patients with Arginase 1 Deficiency

Oct 16, 2018

resTORbio Announces Additional RTB101 Phase 2b Data Demonstrating Decreased Incidence of Laboratory-Confirmed RTIs with Severe Symptoms, Total Infections and UTIs

Oct 16, 2018

PRINCIPIA ACHIEVES $10 MILLION IN ADDITIONAL MILESTONES RELATED TO DEVELOPMENT OF PRN2246/SAR442168

Oct 16, 2018

KALA PHARMACEUTICALS SUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR KPI-121 0.25% FOR DRY EYE DISEASE

Oct 15, 2018

Rhythm Pharmaceuticals Appoints Murray W. Stewart, M.D., as Chief Medical Officer

Oct 15, 2018

Loxo Oncology Announces Receipt of Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-292 for the Treatment of RET Fusion-Positive Thyroid Cancer

Oct 11, 2018

Synthorx Appoints Pratik Shah, Ph.D., to its Board of Directors

Oct 11, 2018

KALA PHARMACEUTICALS ANNOUNCES FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES

Oct 11, 2018

Otsuka and Proteus extend digital drugs tie-up

Oct 10, 2018

Constellation Pharmaceuticals Enhances and Expands Phase 2 MANIFEST Study of CPI-0610 in Myelofibrosis

Oct 10, 2018

Audentes Therapeutics Announces Pricing of Public Offering of Common Stock

Oct 10, 2018

Marinus Pharmaceuticals Names Dr. Rolando Gutíerrez-Esteinou as VP of Clinical Development and Pharmacovigilance

Oct 9, 2018

ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting

Oct 8, 2018

Inspire Medical Systems, Inc. Announces First Implant of New Sensing Lead in Europe

Oct 6, 2018

Loxo Oncology Announces LOXO-292 Durability Update in Patients with RET-Mutant Medullary Thyroid Cancer and RET Fusion-Positive Thyroid Cancer from LIBRETTO-001 at the 88th Annual Meeting of the American Thyroid Association

Oct 5, 2018

Audentes Therapeutics Presents New Positive Interim Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-linked Myotubular Myopathy, at 23rd International Annual Congress of the World Muscle Society

Oct 4, 2018

KANDY THERAPEUTICS PRESENTS NEW COMPELLING DATA WITH LEAD CANDIDATE NT-814 AT THE NORTH AMERICAN MENOPAUSE SOCIETY 2018 ANNUAL MEETING

Oct 3, 2018

Guardant Health Announces Pricing of Initial Public Offering

Oct 3, 2018

ObsEva SA reports additional positive Phase 3 results of IMPLANT 2 trial showing significant increase of Live Birth Rate (LBR) following IVF with Single Embryo Transfer (SET)

Oct 3, 2018

Introducing the Singulex Clarity C. diff toxin A/B assay, a high-sensitivity, high-precision, single-test solution for the diagnosis of true C. difficile infection

Oct 3, 2018

Corvus Pharmaceuticals Announces Publication of Preclinical Results Highlighting Antitumor Activity of CPI-444 in Multiple Tumor Models both as Monotherapy and in Combination Studies

Oct 3, 2018

Audentes Therapeutics Announces Co-Founder and Chief Executive Officer Matthew R. Patterson Appointed Chairman of the Alliance for Regenerative Medicine

Oct 2, 2018

Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer

Oct 2, 2018

Clementia Initiates Phase 1 Clinical Trial of Palovarotene Eye Drop Formulation in Healthy Volunteers

Oct 2, 2018

KALA PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

Oct 2, 2018

Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD

Oct 2, 2018

KALA PHARMACEUTICALS ANNOUNCES FINANCING FROM ATHYRIUM CAPITAL MANAGEMENT TOTALING $110 MILLION

Oct 1, 2018

MODIS THERAPEUTICS ANNOUNCES $30M SERIES A FINANCING

Oct 1, 2018

FDA Grants Rare Pediatric Disease Designation to Pegzilarginase for Arginase 1 Deficiency

Oct 1, 2018

CTI BioPharma Announces the Continuation of PAC203 Study Following Interim Data Review

Sep 28, 2018

Final results of ObsEva SA Phase 2b EDELWEISS trial of Linzagolix show sustained efficacy and Bone Mineral Density safety, for the treatment of endometriosis-associated pain

Sep 28, 2018

Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity

Sep 28, 2018

Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Bardet-Biedl Syndrome and Alström Syndrome at 57th Annual ESPE Meeting

Sep 27, 2018

Selecta Biosciences Appoints Carsten Brunn, Ph.D. as President and Chief Executive Officer

Sep 26, 2018

Arvinas Announces Pricing of Initial Public Offering

Sep 26, 2018

Clementia Announces Updated Phase 2 Part B Data on Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP)

Sep 26, 2018

Genewiz To Be Acquired By Brooks Automation

Sep 25, 2018

Loxo Oncology Announces LOXO-292 Durability Update in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer from LIBRETTO-001 at the IASLC 19th World Conference on Lung Cancer

Sep 25, 2018

Avedro Names Tim Homer Vice President of Health Policy & Market Access in Continued Effort to Expand Market Access and Reimbursement of Cross-Linking

Sep 25, 2018

Marinus Completes Enrollment in its Magnolia Postpartum Depression Study

Sep 25, 2018

Cigna Is Newest Payer to Join Growing List of Commercial Plans Covering Avedro’s FDA-Approved Cross-Linking Procedure—133 Million Lives Covered in Total

Sep 25, 2018

BELLUS Health Announces Appointment of Clinical Advisory Board

Sep 24, 2018

HLS Therapeutics Announces that Amarin's REDUCE-IT™ Cardiovascular Outcomes Study of Vascepa® (icosapent ethyl) Capsules Met Primary Endpoint

Sep 24, 2018

TP Therapeutics Announces Updated Interim Phase 1/2 Clinical Trial Data of Repotrectinib (TPX-0005) in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer Patients at 19th World Conference on Lung Cancer

Sep 24, 2018

OncLive report on Repotrectinib: “Repotrectinib Shows Promising Activity in ROS1+ NSCLC”

Sep 24, 2018

Verrica Pharmaceuticals Inc. Announces Inclusion in Russell 2000® and Russell 3000® Indexes

Sep 20, 2018

Issue of Shares & PDMR Announcement

Sep 20, 2018

SI-BONE Files Registration Statement for Proposed Initial Public Offering

Sep 19, 2018

Silverback Therapeutics Extends Series A to $47.5 Million to Advance Pipeline of First-in-Class Systemically Delivered, Locally Active Therapies

Sep 19, 2018

Alector Initiates Phase 1 Trial of AL001 for the Treatment of Frontotemporal Dementia

Sep 18, 2018

Sonendo Ships a Record 100,000 GentleWave Procedure Instruments

Sep 18, 2018

Principia Biopharma Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters’ Option to Purchase Additional Shares

Sep 18, 2018

resTORbio Appoints Meredith Manning as Chief Commercial Officer

Sep 17, 2018

ORIC Pharmaceuticals appoints Pratik Multani, MD, as Chief Medical Officer

Sep 17, 2018

Xenon Pharmaceuticals Announces Closing of its $63.0 Million Public Offering of Common Shares

Sep 17, 2018

Realm Therapeutics Provides Corporate Update and Hires Advisor to Support Strategic Review including Formal Sale Process

Sep 17, 2018

Ascendis Pharma A/S Announces Support for Children’s Growth Awareness Week and Day 2018

Sep 13, 2018

Principia Biopharma Announces Pricing Of Initial Public Offering

Sep 13, 2018

Acibadem Maslak Hospital in Turkey Introduces Next Generation Cancer Care with MRIdian MR-Image Guided Radiation Therapy

Sep 12, 2018

Verrica Announces Successful Phase 2 Innovate Trial and Complete Enrollment of Phase 3 Trials of VP-102 in Molluscum Contagiosum Ahead of Schedule

Sep 12, 2018

Constellation Pharmaceuticals Congratulates Dr. David Allis and Dr. Michael Grunstein, Winners of the 2018 Lasker Award

Sep 12, 2018

Xenon Pharmaceuticals Announces Pricing of $63.0 Million Public Offering of Common Shares

Sep 11, 2018

Invitae Appoints Chitra Nayak to its Board of Directors

Sep 11, 2018

TELA Bio Announces Publication of Case Series Evaluating OviTex Reinforced BioScaffolds in Hiatal and Inguinal Hernia Repair

Sep 10, 2018

Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program

Sep 10, 2018

Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. To Its Board Of Directors

Sep 10, 2018

CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Provide Update on U.S Federal Circuit Decision Upholding the Ruling by U.S. Patent and Trademark Office in Interference Proceeding Relating to CRISPR/Cas9 Genome Editing Technology

Sep 7, 2018

Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares

Sep 6, 2018

Xenon Expands Ion Channel Neurology Pipeline with Addition of XEN496, a “Phase 3 Ready” Potassium Channel Modulator for the Treatment of Epilepsy

Sep 6, 2018

Verona Pharma Announces Publication of Key Paper on RPL554 in COPD in the European Respiratory Journal

Sep 6, 2018

BeiGene and SpringWorks Therapeutics Enter into Global Clinical Collaboration to Evaluate Targeted Combination Therapy in Advanced Solid Tumors

Sep 5, 2018

Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares

Sep 5, 2018

SpringWorks Therapeutics Announces Appointment of Saqib Islam as Chief Executive Officer

Sep 5, 2018

Loxo Oncology Announces Receipt of Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-292

Sep 5, 2018

Marinus Appoints Scott Braunstein, MD to its Board of Directors

Sep 4, 2018

Constellation Pharmaceuticals Announces Appointments to Board of Directors

Sep 4, 2018

Pieris Pharmaceuticals Announces Dosing Of First Patient In Phase I Combination Trial For Prs-343 Plus Anti-Pd-L1 Immunotherapy

Sep 4, 2018

Synlogic Reports Positive Interim Phase 1/2a Data Demonstrating Safety, Tolerability and Proof-of-Mechanism in Healthy Volunteers for SYNB1618, in Development for the Management of Phenylketonuria (PKU)

Sep 4, 2018

Aeglea BioTherapeutics Announces Positive Interim Clinical Data and Completion of Enrollment for Ongoing Phase 1/2 Trial of Pegzilarginase in Patients with Arginase 1 Deficiency

Aug 30, 2018

Crinetics Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Aug 29, 2018

Ascendis Pharma A/S Reports Second Quarter 2018 Financial Results

Aug 29, 2018

Xenon Announces Positive XEN1101 Pharmacodynamic Data from Phase 1b TMS Study

Aug 29, 2018

Kandy Therapeutics Successfully Raises £25 million in a Series C Financing Funding to Advance a Breakthrough Non-hormonal Treatment for Symptoms of the Menopause, Into a Phase 2b Study in Q4 2018

Aug 27, 2018

Loxo Oncology Announces Submission of European Marketing Authorization Application for Larotrectinib

Aug 23, 2018

E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith as President and Chief Executive Officer

Aug 23, 2018

Intellia Therapeutics Presents Progress in Lead In Vivo Program at Cold Spring Harbor Laboratory’s Fourth Meeting on Genome Engineering: The CRISPR-Cas Revolution

Aug 23, 2018

Kala Pharmaceuticals Announces FDA Approval of Inveltys for the Treatment of Post-operative Inflammation and Pain Following Ocular Surgery

Aug 22, 2018

Sierra Oncology Obtains Debt Facility from Silicon Valley Bank to Acquire and Advance Momelotinib

Aug 22, 2018

Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences

Aug 21, 2018

Audentes Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by the FDA to AT132 for the Treatment of X-Linked Myotubular Myopathy

Aug 20, 2018

Xtant Medical Announces Appointment of Chief Financial Officer

Aug 17, 2018

ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock

Aug 16, 2018

Clementia Announces Completion of Enrollment in Phase 3 MOVE Trial for FOP

Aug 16, 2018

Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer

Aug 15, 2018

Sonendo® Announces GentleWave® System Integration With TDO® Endodontic Software

Aug 15, 2018

resTORbio Appoints Jeffrey Chodakewitz, M.D., to its Board of Directors

Aug 15, 2018

Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort

Aug 15, 2018

Verrica Appoints Neetu Dhaliwal as Vice President of Business Development

Aug 14, 2018

Realm Therapeutics Reports Top-line Data from Phase 2 Trial of PR022 in Atopic Dermatitis and First Half 2018 Financial Results

Aug 14, 2018

Aerpio Reports Second Quarter 2018 Financial Results and Provides Business Update

Aug 14, 2018

scPharmaceuticals Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

Aug 14, 2018

Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2018 Financial Results

Aug 13, 2018

Arsanis Reports Financial Results for Second Quarter 2018

Aug 13, 2018

Synlogic Publishes Preclinical Data Supporting Development of SYNB1618, a Synthetic Biotic™ Medicine as a Potential Treatment for Phenylketonuria

Aug 9, 2018

Loxo Oncology Reports Second Quarter 2018 Financial Results

Aug 9, 2018

Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Aug 9, 2018

Aeglea BioTherapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results

Aug 9, 2018

Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2018 Financial Results

Aug 9, 2018

Clementia Reports Second Quarter 2018 Operating Results and Pipeline Updates

Aug 9, 2018

Kala Pharmaceuticals Reports Second Quarter 2018 Financial Results

Aug 9, 2018

resTORbio Reports Second Quarter 2018 Financial Results

Aug 9, 2018

Nabriva Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

Aug 9, 2018

Sierra Oncology Reports Second Quarter Results

Aug 8, 2018

Synlogic Reports Second Quarter 2018 Financial Results and Provides Program Updates

Aug 8, 2018

Cyrus Biotechnology Appoints Jake Litwicki as VP of Engineering

Aug 8, 2018

Alector Receives Orphan Drug Designation from the U.S. FDA for AL001 for the Treatment of Frontotemporal Dementia

Aug 8, 2018

ObsEva reports Second Quarter 2018 Financial Results and Provides Business Update

Aug 8, 2018

Tricida Announces Second Quarter 2018 Financial Results and Provides Update on Key Initiatives

Aug 8, 2018

Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results

Aug 8, 2018

Selecta Biosciences Announces Second Quarter 2018 Financial Results and Provides Corporate Update

Aug 7, 2018

Invitae Reports More than 160% Annual Revenue Growth Driven by Nearly 140% Annual Growth in Volume in Second Quarter 2018

Aug 7, 2018

Inspire Medical Systems, Inc. Announces Second Quarter 2018 Financial Results

Aug 7, 2018

Audentes Therapeutics Reports Second Quarter 2018 Financial Results and Provides Update on ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy

Aug 7, 2018

SI-BONE, Inc. Announces 23 Commercial Health Insurance Plans Now “Exclusively” Cover Triangular iFuse Implant System® Based on Published Clinical Evidence

Aug 7, 2018

Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Aug 7, 2018

Verrica Reports Second Quarter 2018 Financial Results

Aug 7, 2018

Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2018

Aug 6, 2018

OmniGuide, Inc. to Acquire Lisa Laser, Developer of Surgical Laser Products

Aug 6, 2018

Alpine Immune Sciences Strengthens Leadership Team with Appointment of Mark Litton as President and Chief Operating Officer

Aug 3, 2018

ViewRay Reports Second Quarter 2018 Financial Results

Aug 2, 2018

Marinus Pharmaceuticals Provides Business Update and Second Quarter 2018 Financial Results

Aug 2, 2018

CTI BioPharma Reports Second Quarter 2018 Financial Results

Aug 2, 2018

Adaptimmune Reports Second Quarter 2018 Financial Results and Business Update

Aug 2, 2018

Corvus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

Aug 1, 2018

Tricida Announces Hiring of Dawn Parsell as Senior Vice President of Clinical Development

Aug 1, 2018

Verona Pharma Initiates Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment

Aug 1, 2018

ReViral announces US$55 million series B fundraising to advance RSV clinical studies

Aug 1, 2018

Intellia Therapeutics Announces Second Quarter 2018 Financial Results

Jul 31, 2018

Kala Pharmaceuticals Announces Dosing of First Patient in Phase 3 STRIDE 3 Trial of KPI-121 0.25% in Patients with Dry Eye Disease

Jul 31, 2018

Thomas W. Burns, CEO of Glaukos, Joins Avedro's Board of Directors

Jul 26, 2018

Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million

Jul 26, 2018

Principia Confirms Human CNS Exposure and Good Tolerability of Oral BTK Inhibitor PRN2246

Jul 25, 2018

ObsEva Expands Executive Team Hiring a Chief Commercial Officer

Jul 25, 2018

resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101

Jul 25, 2018

Alector Announces $133 Million in Series E Financing to Advance Broad Portfolio of Immuno-Neurology and Immuno-Oncology Programs

Jul 24, 2018

Nabriva Therapeutics Strengthens Antibiotics Leadership Position with Acquisition of Zavante Therapeutics

Jul 24, 2018

GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK

Jul 24, 2018

ViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a Member of the Board of Directors

Jul 24, 2018

scPharmaceuticals Announces Appointment of Two New Director

Jul 23, 2018

Ascendis Pharma A/S Announces First Presentation of Preclinical Data Utilizing TransCon™ Technology in Oncology at SITC 2019

Jul 23, 2018

Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity

Jul 20, 2018

Alpine Immune Sciences Completes Sale of S-Nitrosoglutathione Reductase (GSNOR) Assets to Laurel Venture Capital

Jul 20, 2018

Crinetics Pharmaceuticals Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Jul 19, 2018

Aeglea BioTherapeutics Appoints Dr. Anthony G. Quinn as President and Chief Executive Officer

Jul 18, 2018

CTI BioPharma Announces Pacritinib Program Update Following Type B Meeting with U.S. FDA

Jul 18, 2018

Adaptimmune Announces Favorable Review of Safety from One Billion Cell Dose Cohort in MAGE-A10 SPEAR T-cell Study and Initiation of Third Dosing Cohorts

Jul 18, 2018

Constellation Pharmaceuticals Announces Pricing of Initial Public Offering

Jul 16, 2018

Aeglea BioTherapeutics Appoints Dr. Bryan Lawlis to Board of Directors

Jul 13, 2018

Clementia Appoints Experienced Financial Executive Steve Forte as Chief Financial Officer

Jul 12, 2018

Synthorx Expands Leadership Team with Three Key Hires

Jul 12, 2018

Xenon Pharmaceuticals Announces At-The-Market Equity Offering

Jul 11, 2018

resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older

Jul 10, 2018

Cyrus Biotechnology Launches Immune Epitope Prediction Software

Jul 10, 2018

Realm Therapeutics Announces Publication of Pre-Clinical Study Demonstrating Comparable Activity of PR022 and Topical Tofacitinib in the Treatment of Atopic Dermatitis

Jul 9, 2018

Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of PIXUVRI® (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma

Jul 5, 2018

Clementia Appoints Industry Executive Shawn Tomasello to its Board of Directors

Jul 4, 2018

Realm Therapeutics Announces U.S. SEC Declares Registration Statement Effective and NASDAQ Approves Listing of ADSs Representing Ordinary Shares

Jul 2, 2018

CTI BioPharma Announces the Continuation without Modification of PAC203 Phase 2 Study of Pacritinib in Patients with Myelofibrosis Previously Treated with Ruxolitinib

Jul 2, 2018

Tricida Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jun 28, 2018

Corvus Pharmaceuticals Announces Publication of Preclinical Study Results Demonstrating CPI-444 Antitumor Activity as Monotherapy and in Combination with Anti-PD-1 Therapy in Cancer Immunology, Immunotherapy

Jun 28, 2018

Arsanis Provides Update Following Completion of Planned Interim Analysis of Phase 2 Clinical Trial of ASN100

Jun 28, 2018

scPharmaceuticals Appoints Frederick Hudson to Board of Directors

Jun 27, 2018

Inspire Medical Systems, Inc. Announces Regulatory Approval of Inspire Therapy for Treatment of Moderate to Severe Obstructive Sleep Apnea in Japan

Jun 27, 2018

Adicet Bio appoints Stewart Abbot, Ph.D. as Chief Scientific Officer

Jun 26, 2018

Aerpio Pharmaceuticals Announces Uplisting to Nasdaq Capital Market and Pricing of $45.0 Million Public Offering of Common Stock

Jun 25, 2018

Aerpio Pharmaceuticals Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market

Jun 25, 2018

Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Jun 25, 2018

Synlogic Presents New Preclinical Data from Synthetic Biotic™ Immuno-Oncology Program at FOCIS 2018

Jun 25, 2018

Invitae Expands Reproductive Health Offering with Launch of Comprehensive Genetic Carrier Screening

Jun 25, 2018

Aerpio Announces Exclusive License Agreement with Gossamer Bio for AKB-4924, a First in Class Hypoxia-Inducible Factor-1 Alpha Stabilizer in Development for Inflammatory Bowel Disease

Jun 22, 2018

Lilly Completes Acquisition of ARMO BioSciences

Jun 21, 2018

Kandy Therapeutics and Nerre Therapeutics Announce the Appointment of Jo Craig as Head of Chemistry Manufacturing and Controls

Jun 21, 2018

Natera Develops Powerful Kidney Transplant Rejection Biomarker

Jun 21, 2018

University of Wisconsin Begins Patient Treatments with ViewRay's MRIdian Linac

Jun 21, 2018

Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Congenital Hyperinsulinism and Acromegaly

Jun 21, 2018

KaNDy Therapeutics and NeRRe Therapeutics announce the appointment of Jo Craig as Head of Chemistry Manufacturing and Controls

Jun 20, 2018

ObsEva Announces Pricing of Follow-on Public Offering

Jun 19, 2018

CRISPR Therapeutics, Intellia Therapeutics and Caribou Biosciences Announce Grant of U.S. Patent for CRISPR/Cas9 Genome Editing

Jun 19, 2018

Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder

Jun 19, 2018

Verrica Pharmaceuticals Inc. Announces Closing of Initial Public Offering

Jun 19, 2018

Kala Pharmaceuticals Announces Update to KPI-121 0.25% Development Plan

Jun 18, 2018

ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis

Jun 18, 2018

Avedro Announces Enrollment of First Patient in U.S. Pivotal Phase 3 Epi-on Corneal Cross-Linking Trial for Progressive Keratoconus

Jun 18, 2018

Crinetics Pharmaceuticals Appoints Alan Krasner, M.D., as Chief Medical Officer

Jun 18, 2018

Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity

Jun 15, 2018

Selecta Biosciences Presents Data from Ongoing Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at EULAR 2018

Jun 14, 2018

Arsanis Out-Licenses Preclinical Stage Klebsiella pneumoniae Monoclonal Antibodies from ASN300 Program

Jun 14, 2018

Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity

Jun 13, 2018

Pioneer of MR Image-Guided Radiotherapy, Washington University, Begins First Clinical Treatments with its Second ViewRay MRIdian System

Jun 13, 2018

Synlogic Presents New Preclinical Data from Synthetic Biotic™ Medicine, SYNB1020, Highlighting Beneficial Activity in Animal Model of Liver Disease at Digestive Disease Week

Jun 13, 2018

Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing

Jun 12, 2018

E-Scape Bio Obtains Worldwide Rights from AbbVie for Selective S1P5 Program Targeting CNS-related Lysosomal Storage Disorders

Jun 12, 2018

resTORbio Announces Appointment of Kerry Russell, M.D., Ph.D., as Vice President of Clinical Development

Jun 11, 2018

Synlogic Presents Preclinical Data from Synthetic BioticTM Medicine, SYNB1618, for the Treatment of Phenylketonuria

Jun 11, 2018

Study published in Cancer Discovery Indicates that NY-ESO SPEAR T-cells are Long-lived, Self?renewing, and Capable of Persistent Anti-Tumor Effects

Jun 7, 2018

Kandy Therapeutics Announces Positive Clinical Data with Lead Candidate Nt-814 for the Treatment of Symptoms of the Menopause

Jun 7, 2018

Inspire Medical Systems, Inc. Reports First Quarter 2018 Financial Results

Jun 6, 2018

Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism

Jun 5, 2018

Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment of X-Linked Myotubular Myopathy

Jun 5, 2018

Tricida Announces Positive Pivotal Phase 3 Clinical Trial Results for TRC101 in CKD Patients with Metabolic Acidosis

Jun 4, 2018

TP Therapeutics Announces Interim Data from the Phase 1/2 Clinical Trial of Investigational Agent TPX-0005 at ASCO 2018: Data Presented from the Ongoing TRIDENT-1 Study

Jun 4, 2018

Synlogic Presents New Preclinical Data from Synthetic Biotic™ Medicine, SYNB1020, Highlighting Beneficial Activity in Animal Model of Liver Disease at Digestive Disease Week

Jun 4, 2018

Adaptimmune Presents Detailed Safety Update from Ongoing MAGE-A10 Pilot Studies at ASCO

Jun 4, 2018

Adaptimmune Announces First Patient to Receive One Billion Target Cell Dose after Positive Safety Data from Pilot Study with MAGE-A4 SPEAR T-cells

Jun 4, 2018

Tricida Announces Kathryn Falberg Joins Board of Directors

Jun 2, 2018

Updated Myxoid/Round Cell Liposarcoma Data with NY-ESO, Presented at ASCO Annual Meeting, Further Supports Promising Benefit: Risk Profile

Jun 2, 2018

Loxo Oncology Announces Positive Interim Clinical Data from LOXO-292 Dose Escalation Trial in RET-Altered Cancers Presented at the American Society of Clinical Oncology Annual Meeting

Jun 1, 2018

ObsEva SA to Seek SIX Share Listing

Jun 1, 2018

NeuroPace Launches Next Generation RNS System, the World’s Only Brain-Computer Interface for the Treatment of Refractory Epilepsy

May 31, 2018

scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX®

May 31, 2018

Nabriva Therapeutics to Present Lefamulin Data at ASM Microbe

May 30, 2018

Ascendis Pharma A/S Reports First Quarter 2018 Financial Results

May 29, 2018

FDA Accepts Larotrectinib New Drug Application and Grants Priority Review

May 24, 2018

Realm Therapeutics Completes Enrollment in Phase 2 Study of PR022 for Atopic Dermatitis

May 23, 2018

Realm Therapeutics Publicly Files Registration Statement with the U.S. SEC to Facilitate Nasdaq Listing of ADSs Representing Ordinary Shares

May 23, 2018

World-Leading Oncologists to Meet in Miami for Adaptive MR Image-Guided Radiotherapy Symposium

May 23, 2018

Clementia Reports Positive Phase 2 Part B Data Showing Treatment with Palovarotene Significantly Reduces New Bone Growth in Patients with FOP

May 22, 2018

OmniGuide Surgical Announces Commercial Launch of C-LAS Line of Sight CO2 Laser System

May 22, 2018

resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition

May 21, 2018

Xtant Medical Receives FDA 510(K) Clearance for InTice™-C Porous Titanium Cervical Interbody System

May 21, 2018

Verona Pharma Presented Clinical Data at ATS 2018 that Further Highlights RPL554 as a First-in-Class Treatment for COPD

May 21, 2018

Nabriva Therapeutics Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of Oral Lefamulin for the Treatment of Community-Acquired Bacterial Pneumonia

May 21, 2018

Cerapedics Announces Results From IVANOS Study of i-FACTOR Peptide Enhanced Bone Graft

May 17, 2018

TP Therapeutics Announces Phase 1 Data of Ropotrectinib (TPX-0005) to be Presented at the Annual American Society of Clinical Oncology Meeting

May 17, 2018

Intellia Therapeutics Announces WT1 as Its First Cell Therapy Target, Following Presentation of Early Data at the American Society of Gene and Cell Therapy 21st Annual Meeting

May 17, 2018

Pharming Group Interim Report on Financial Results for the First Quarter 2018

May 16, 2018

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update

May 16, 2018

Loxo Oncology Announces Details of LOXO-292 Clinical Data Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

May 16, 2018

Myxoid/Round Cell Liposarcoma Data with NY-ESO and MAGE-A10 Study Update to be Presented at American Association for Clinical Oncology (ASCO) Annual Meeting

May 16, 2018

Audentes Announces Continuing Positive Data from First Dose Cohort of ASPIRO, a Phase 1/2 Clinical Trial of AT132 in Patients With X-Linked Myotubular Myopathy

May 15, 2018

Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update

May 15, 2018

Xenon Presents Positive XEN1101 TMS Pharmacodynamic Phase 1 Data at 14th Eilat Conference

May 15, 2018

Xenon Presents XEN901 Phase 1 Clinical Update and Supporting Pre-clinical Data at 14th Eilat Conference

May 14, 2018

Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2018 Financial Results

May 14, 2018

Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results

May 10, 2018

Sierra Oncology Reports First Quarter Results

May 10, 2018

ViewRay Reports First Quarter 2018 Financial Results

May 10, 2018

Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results And Provides Corporate Update

May 10, 2018

Synlogic Announces Leadership Change

May 10, 2018

Kala Pharmaceuticals Reports First Quarter 2018 Financial Results

May 10, 2018

Lilly Announces Agreement To Acquire ARMO BioSciences

May 10, 2018

resTORbio Reports First Quarter 2018 Financial Results

May 10, 2018

Arsanis Reports Business Highlights and Financial Results for First Quarter 2018

May 9, 2018

Audentes Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update

May 9, 2018

Clementia Reports First Quarter 2018 Operating Results and Pipeline Updates

May 9, 2018

Rhythm Pharmaceuticals Announces Nature Medicine Publication of Longer-Term Data from Phase 2 Study of Setmelanotide for Treatment of LEPR Deficiency Obesity

May 9, 2018

Adaptimmune Reports First Quarter 2018 Financial Results and Business Update

May 9, 2018

Invitae Reports 169% Revenue Growth Driven by 150% Growth in Volume in First Quarter 2018

May 9, 2018

resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly

May 9, 2018

Kala Pharmaceuticals Strengthens Commercial Organization In Preparation For First Product Launch

May 9, 2018

Selecta Biosciences Announces First Quarter 2018 Financial Results and Provides Corporate Update

May 8, 2018

Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Result

May 8, 2018

Ascendis Pharma A/S Announces Dosing of First Subjects in Phase 1 Trial of TransCon CNP

May 8, 2018

Natera Reports First Quarter 2018 Financial Results

May 8, 2018

Xenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update

May 8, 2018

First Cardiac Procedure Using the AcQMap® System by Acutus Medical® Successfully Performed in the United States

May 8, 2018

Audentes Therapeutics Announces the Promotion of Natalie Holles to President and Chief Operating Officer

May 8, 2018

Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights

May 8, 2018

Loxo Oncology Reports First Quarter 2018 Financial Results

May 7, 2018

Inspire Medical Systems, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 7, 2018

Sarepta and Invitae Expand Partnership to Advance Clinical Research in Duchenne Muscular Dystrophy

May 7, 2018

ORIC has appointed Jacob Chacko, MD as Chief Executive Officer

May 7, 2018

scPharmaceuticals Inc. Reports First Quarter 2018 Financial Results and Provides Business Update

May 7, 2018

Ascendis Pharma A/S Announces Poster Presentation on TransCon PTH Phase 1 Trial at the European Congress of Endocrinology

May 3, 2018

CTI BioPharma Reports First Quarter 2018 Financial Results

May 3, 2018

Stereotaxis and Acutus Medical Announce Strategic Collaboration

May 3, 2018

Corvus Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update

May 2, 2018

Final Results for the Year Ended December 31, 2017 and Business Update

May 2, 2018

Avedro Announces $25 Million in Funding to Fuel Innovation and Commercial Growth

May 2, 2018

Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results

May 1, 2018

Intellia Therapeutics Announces First Quarter 2018 Financial Results

Apr 30, 2018

Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin™ Cytokines

Apr 30, 2018

Miami Cancer Institute at Baptist Health South Florida Becomes Second Institution in the United States to Treat Patients with ViewRay’s MRIdian® Linac

Apr 30, 2018

Adicet Bio Appoints Elizabeth “E.J.” Read, M.D. as its Chief Technology Officer

Apr 30, 2018

Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough

Apr 30, 2018

Adicet Bio Appoints Elizabeth “E.J.” Read, M.D. as its Chief Technology Officer

Apr 27, 2018

Invitae Announces New Program to Offer Genetic Testing to Aid Diagnosis of Spinal Muscular Atrophy (SMA)

Apr 27, 2018

Avedro Announces $25 Million in Funding to Fuel Innovation and Commercial Growth

Apr 26, 2018

Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006, in Patients with Advanced Cancer

Apr 25, 2018

ARMO BioSciences Announces Poster Presentations of Pegilodecakin (AM0010) at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Apr 25, 2018

Pieris Pharmaceuticals Appoints Ann Barbier, M.D., Ph.D., To Its Board Of Directors

Apr 24, 2018

Sonendo Ships 50,000 GentleWave Procedure Instruments to Endodontists

Apr 24, 2018

Singulex Clarity C. diff toxins A/B assay in development shown to be ultrasensitive and highly specific compared with currently available testing options

Apr 23, 2018

Intellia Therapeutics Announces In Vivo and Ex Vivo Data Presentations at the American Society of Gene and Cell Therapy 21st Annual Meeting

Apr 23, 2018

Graybug Vision Announces Presentations on Novel Treatments for Wet AMD and Glaucoma at ARVO 2018 Annual Meeting

Apr 23, 2018

Inspire Medical Systems, Inc. Announces Commencement of its Initial Public Offering

Apr 23, 2018

ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)

Apr 20, 2018

Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas

Apr 19, 2018

Cyrus Biotechnology Exhibits at the PEGS Protein Engineering Summit in Boston, April 30th May 3rd

Apr 19, 2018

VU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR Image-Guided Radiotherapy Treatment on ViewRay MRIdian Linac

Apr 18, 2018

Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria

Apr 18, 2018

ViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy

Apr 18, 2018

Aeglea BioTherapeutics Prices Public Offering of Common Stock

Apr 17, 2018

Sierra Late-Breaking Data Demonstrating SRA737 Preclinical Activity with PARPi to be Presented at the AACR 2018 Annual Meeting

Apr 17, 2018

Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock

Apr 17, 2018

Alpine Immune Sciences Announces Preclinical Data Demonstrating ALPN-202 Eliminates Tumors and Creates Persistent Tumor Resistance in a Murine Cancer Model

Apr 16, 2018

Summary ToggleSynlogic Presents Preclinical Data from Synthetic Biotic Immuno-Oncology Program at the American Association for Cancer Research 2018 Annual Meeting

Apr 16, 2018

Adaptimmune Presents MAGE-A4 and MAGE-A10 pre-clinical data at American Association for Cancer Research (AACR) Annual Meeting

Apr 16, 2018

TELA Bio Announces Series B Investment by Checkmate Capital

Apr 13, 2018

Nabriva Therapeutics to Present Data at ECCMID Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia

Apr 12, 2018

Aeglea BioTherapeutics Presents New Phase 1/2 Trial Data Demonstrating Clinically Relevant Treatment Effects in Arginase 1 Deficiency Patients at the 2018 ACMG Annual Clinical Genetics Meeting

Apr 10, 2018

Avedro Names James Schuermann Chief Business Officer

Apr 10, 2018

Invitae research highlights utility of proactive genetic screening, importance of assessing secondary findings in genetic testing

Apr 10, 2018

Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

Apr 9, 2018

Constellation Pharmaceuticals Announces $100 Million Financing

Apr 9, 2018

Kala Pharmaceuticals to Present at the 2018 American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) and at the Ophthalmology Innovation Summit at ASCRS

Apr 9, 2018

SI-BONE, Inc. Hosts ISASS 2018 Sacroiliac Joint Workshop led by David Polly, MD, Bengt Sturesson, MD, Peter Whang, MD and Brad Duhon, MD

Apr 9, 2018

SI-BONE, Inc. Announces Publication of 3-Year Long-term Prospective Outcomes Including Randomized Controlled Trial Data on 103 Patients Post SI Joint Fusion with Triangular iFuse Implant System

Apr 6, 2018

Inspire Medical Systems, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering

Apr 6, 2018

Summary ToggleSynlogic Announces Registered Direct Offering of Common Stock

Apr 5, 2018

Aeglea BioTherapeutics to Present Pegzilarginase Phase 1 Dose Escalation Data in Patients with Advanced Solid Tumors at 2018 AACR Annual Meeting

Apr 4, 2018

NextCure Appoints Kevin N. Heller, M.D., as Chief Medical Officer and Steve Cobourn, CPA, as Chief Financial Officer.

Apr 4, 2018

Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform

Apr 4, 2018

University Clinic Heidelberg Completes Installation and Commissioning of ViewRay's MRIdian MR Image-Guided Radiotherapy Linac

Apr 4, 2018

Loxo Oncology Announces Acceptance of LOXO-292 Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting

Apr 2, 2018

Synlogic Doses First Patient in Phase 1b/2a Trial of SYNB1020 for Treatment of Hyperammonemia in Patients with Cirrhosis

Apr 2, 2018

Ascendis Pharma A/S Appoints Thomas A. Larson as Chief Commercial Officer

Apr 2, 2018

Aeglea BioTherapeutics Doses First Small Cell Lung Cancer Patients with Pegzilarginase in Both Monotherapy and KEYTRUDA (Pembrolizumab) Combination Trials

Apr 2, 2018

Rhythm Pharmaceuticals Announces Licensing Agreement with Takeda for the Development and Commercialization of Preclinical Treatment for Prader-Willi Syndrome

Mar 29, 2018

resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results

Mar 29, 2018

HLS Therapeutics Announces Fiscal 2017 Financial Results

Mar 28, 2018

Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange Agreement with BVF Partners L.P.

Mar 28, 2018

Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2017 Financial Results

Mar 28, 2018

Invitae Announces Pricing of Public Offering of Common Stock

Mar 28, 2018

Ascendis Pharma A/S Reports Full Year 2017 Financial Results

Mar 27, 2018

Nabriva Therapeutics and Roivant Sciences Enter into License Agreement to Develop and Commercialize Lefamulin in Greater China

Mar 27, 2018

ViewRay Surpasses 50th Order for MRIdian System for Precision Cancer Treatment

Mar 26, 2018

Invitae Announces Proposed Public Offering of Common Stock

Mar 26, 2018

Loxo Oncology Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Larotrectinib for the Treatment of TRK Fusion Cancer

Mar 26, 2018

Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

Mar 26, 2018

TELA Bio Announces Investment Agreement with ProMedica Innovations Venture Fund

Mar 23, 2018

Invitae expands network of patients in rare and ultra-rare diseases

Mar 21, 2018

Kyn Therapeutics Appoints Chairman and Scientific Advisory Board Member

Mar 21, 2018

Study shows cardiac troponin measurement using ultra-sensitive Singulex cTnI test can identify the presence and severity of coronary artery disease in stable, symptomatic outpatients

Mar 21, 2018

Nabriva Therapeutics Appoints Jennifer Schranz, M.D., as Chief Medical Officer

Mar 20, 2018

ReViral to present at American Chemical Society

Mar 20, 2018

Synlogic Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Mar 20, 2018

scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results

Mar 19, 2018

Ascendis Pharma Announces Two Posters on Rare Disease Pipeline Programs at ENDO 2018

Mar 19, 2018

PMV Pharma Appoints Salim Yazji, M.D. as Chief Medical Officer

Mar 19, 2018

Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting

Mar 19, 2018

resTORbio Announces Formation of Clinical Advisory Board

Mar 19, 2018

Rhythm Pharmaceuticals Announces Presentation of Genetic Epidemiology of LEPR, POMC, And PCSK1 Variants at ENDO 2018

Mar 16, 2018

HLS Therapeutics Inc. Opens the Market

Mar 16, 2018

Nearly 200 Oncology Experts Gather to Discuss Advanced Applications of MR Image-Guided Radiotherapy

Mar 16, 2018

Invitae partners with KEW, Inc. to develop somatic mutation detection capabilities to improve cancer care by providing comprehensive genomic information

Mar 16, 2018

Nabriva Therapeutics Reports 2017 Financial Results and Recent Corporate Highlights

Mar 16, 2018

Ascendis Pharma A/S Announces Year-End 2017 Financial Results and Business Update Conference Call on March 28

Mar 15, 2018

Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update

Mar 15, 2018

Adaptimmune Announces Responses in Second Solid Tumor Indication with NY-ESO SPEAR T-cells

Mar 15, 2018

ViewRay's MRIdian MR Image-Guided Radiotherapy Linac Receives Japanese Regulatory Approval (Shonin)

Mar 14, 2018

ViewRay Finalizes Order for MR Image-Guided Radiation Therapy System at University Hospital Zurich

Mar 14, 2018

Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies

Mar 14, 2018

Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery

Mar 14, 2018

HLS Therapeutics Completes Merger with Automodular Corporation

Mar 14, 2018

Late-Breaking Abstract Reporting SRA737 Preclinical Activity in CCNE1-Driven and PARPi-Resistant Cancers Accepted for AACR 2018 Annual Meeting

Mar 14, 2018

Intellia Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results

Mar 14, 2018

Alpine Immune Sciences Announces Poster Presentation at the 2018 AACR Annual Meeting

Mar 13, 2018

Study adds to understanding about utility of ultra-sensitive cardiac troponin measurement in diagnosing and predicting cardiovascular syndromes

Mar 13, 2018

Crinetics Pharmaceuticals Completes $63.5 Million Series B Financing

Mar 13, 2018

Natera Reports Fourth Quarter and Fiscal Year 2017 Financial Results

Mar 13, 2018

Aeglea BioTherapeutics Provides Key Clinical Data Update from Phase 1/2 Trial in Arginase 1 Deficiency and Reports Q4 and Full Year 2017 Financial Results

Mar 13, 2018

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Mar 13, 2018

Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer

Mar 12, 2018

ViewRay Reports Fourth Quarter and Full Year 2017 Financial Results

Mar 12, 2018

Realm Therapeutics Provides Clinical Update, including Results from a Phase 2 Study of PR013 in Allergic Conjunctivitis

Mar 12, 2018

Synlogic Presents Clinical and Preclinical Data from Synthetic Biotic™ Medicine Programs for Treatment of Inborn Errors of Metabolism at Annual Meeting of The Society for Inherited Metabolic Disorders

Mar 12, 2018

Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock

Mar 12, 2018

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results

Mar 9, 2018

Pieris Pharmaceuticals Reports Full-Year 2017 Financial Results And Corporate Update

Mar 9, 2018

Arsanis Reports Financial Results and Highlights for Fourth Quarter and Full Year 2017

Mar 9, 2018

ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update

Mar 9, 2018

CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology

Mar 8, 2018

Audentes Therapeutics Reports Fourth Quarter 2017 and Full Year Financial Results and Provides Corporate Update

Mar 8, 2018

Prevail Therapeutics Announces $75 Million Series A Financing to Advance Gene Therapies for Patients with Parkinson's and Other Neurodegenerative Diseases

Mar 8, 2018

Aeglea BioTherapeutics Doses First Uveal and Cutaneous Melanoma Patients in Phase 1 Cohort Expansions with Pegzilarginase

Mar 7, 2018

Pharming Group Report on Preliminary Financial Results for 2017

Mar 7, 2018

TigerConnect Teams with QGenda

Mar 7, 2018

CTI BioPharma Reports Fourth Quarter and Full Year 2017 Financial Results

Mar 7, 2018

Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update

Mar 6, 2018

Marinus Pharmaceuticals Provides Business Update and 2017 Financial Results

Mar 6, 2018

Aeglea BioTherapeutics to Present Adult Repeat Dose Data at 2018 Annual Meeting of The Society for Inherited Metabolic Disorders

Mar 6, 2018

TigerText Renames As TigerConnect to Welcome a New Era of Clinical Communication

Mar 5, 2018

Kala Pharmaceuticals Appoints Gregory Perry To Board Of Directors And As Audit Committee Chair

Mar 2, 2018

Sierra Oncology Announces Pricing of Public Offering of Common Stock

Mar 2, 2018

Tricida Announces $100 Million Venture Debt Financing From Hercules Capital

Mar 2, 2018

Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients

Mar 1, 2018

Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

Mar 1, 2018

ObsEva Announces Presentations Related to its Pre-term labor (PTL) Development Program at SRI 2018 Annual Meeting

Mar 1, 2018

Loxo Oncology Reports Fourth Quarter and Year-End 2017 Financial Results

Feb 28, 2018

Aerpio Pharmaceuticals Presents Analysis from TIME-2 Study Regarding Effects of AKB-9778 on Renal Function at 2018 Keystone Symposium on Reducing the Burden of Diabetes Related End-Organ Injury

Feb 28, 2018

Study shows high-sensitivity cardiac troponin I concentrations is an independent predictor of obstructive coronary artery disease in patients with suspected stable angina

Feb 28, 2018

Clementia Reports 2017 Operating Results and Business Highlights

Feb 27, 2018

Verona Pharma Reports Operational Update and Financial Results for Full Year Ended December 31, 2017

Feb 27, 2018

Sierra Oncology Reports 2017 Year End Results

Feb 27, 2018

Invitae expands existing credit facility to provide up to $40.0 million in available growth capital

Feb 26, 2018

ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF

Feb 21, 2018

Sierra to Report Preclinical Data Demonstrating SRA737 Synergy with PARPi at the AACR 2018 Annual Meeting

Feb 21, 2018

Loxo Oncology Announces Publication of Larotrectinib Clinical Data in The New England Journal of Medicine

Feb 20, 2018

Ascendis Pharma A/S Announces Proposed Public Offering of ADSs

Feb 20, 2018

Xenon Pharmaceuticals Advances Second Proprietary Epilepsy Product into the Clinic with Initiation of XEN901 Phase 1 Clinical Trial

Feb 16, 2018

Pieris Pharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares

Feb 15, 2018

Realm Therapeutics Highlights Strong 2017 Performance and Outlines 2018 Milestones

Feb 14, 2018

Xtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private Placement

Feb 14, 2018

Pieris Pharmaceuticals Announces Pricing of its Public Offering

Feb 13, 2018

Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic� Medicine

Feb 13, 2018

CTI BioPharma Announces Closing Of Underwritten Public Offering Of Common Stock

Feb 13, 2018

Verona Pharma Provides Clinical Development Update

Feb 13, 2018

Pieris Pharmaceuticals Announces Public Offering of Common Stock

Feb 12, 2018

Audentes Therapeutics Announces Dosing of First Patient in VALENS, a Phase 1/2 Clinical Trial of AT342 for the treatment of Crigler-Najjar Syndrome

Feb 12, 2018

Invitae reports over 150% volume and over 170% revenue growth for 2017

Feb 10, 2018

Corvus Pharmaceuticals Announces Presentation of New Data from Preclinical Study of Novel T-Cell Signaling Pathway Inhibitor at 10th Annual T-Cell Lymphoma Forum

Feb 9, 2018

Aerpio Pharmaceuticals Completes Patient Enrollment in TIME-2b Study, a Phase 2b Clinical Trial of Lead Candidate AKB-9778 in Patients with Diabetic Retinopathy

Feb 9, 2018

CTI BioPharma Prices Underwritten Public Offering of $60 Million of Common Stock

Feb 9, 2018

Arvinas Presents New Preclinical Data on Oral Androgen Receptor PROTAC® ARV-110 at ASCO 2018 Genitourinary Cancers Symposium

Feb 9, 2018

Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration

Feb 8, 2018

Glaukos iStent® Trabecular Micro-Bypass Stent Reduced IOP and Lowered Medication Burden in Patients with Severe Glaucoma, According to New Study

Feb 6, 2018

Sierra Oncology to host Program Update in New York on February 27th

Feb 6, 2018

Audentes Therapeutics Announces Selection of Optimized Clinical Development Candidate for Pompe Disease Program

Feb 5, 2018

Positive results achieved in ReViral’s Phase IIa RSV challenge study

Feb 5, 2018

CTI BioPharma Announces Launch of Follow-On Offering

Jan 31, 2018

Summary ToggleSynlogic Announces Underwriters’ Option Exercise in Full

Jan 31, 2018

Clementia Appoints Industry Veteran Pierre Legault to its Board of Directors

Jan 30, 2018

resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jan 29, 2018

Audentes Therapeutics Announces the Closing of its Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Jan 29, 2018

Sierra Oncology to Present at the DNA Damage Response Therapeutics Summit

Jan 25, 2018

resTORbio Announces Pricing of Initial Public Offering

Jan 25, 2018

CTI BioPharma Provides Corporate and European Regulatory Update

Jan 25, 2018

ARMO BioSciences Announces Pricing of Initial Public Offering

Jan 24, 2018

Audentes Therapeutics Announces Pricing of Public Offering of Common Stock

Jan 24, 2018

Synlogic Announces Pricing of Public Offering of Common Stock

Jan 18, 2018

CTI BioPharma to Receive $10 Million Milestone Payment for TRISENOX

Jan 18, 2018

Aeglea BioTherapeutics to Present Preclinical Data at 2018 Keystone Symposia Tumor Metabolism Conference

Jan 17, 2018

Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST® for Prophylaxis of Hereditary Angioedema Attacks

Jan 11, 2018

Adimab Initiates Update on Clinical Progression of Partner Programs

Jan 10, 2018

Glaukos Corporation’s iDose™ Travoprost Achieves Sustained IOP Reduction and Favorable Safety Profile in 12-Month Interim Cohort

Jan 10, 2018

Adimab Announces Antibody Discovery Collaboration with Boehringer Ingelheim

Jan 8, 2018

Invitae more than doubles annual volume, exceeds full-year 2017 guidance, and projects momentum to continue in 2018

Jan 8, 2018

Ascendis Pharma Provides Update on Rare Disease Endocrinology Pipeline and Presents Initial Phase 1 Data for TransCon PTH

Jan 8, 2018

Adaptimmune Announces Positive Safety Data from Pilot Studies with MAGE-A10 SPEAR T-cells and First Patient to Receive 1 billion Target Cell Dose

Jan 8, 2018

ViewRay Announces Preliminary Fourth Quarter and Fiscal Year 2017 Results

Jan 8, 2018

Adaptimmune Announces Two Manufacturing Achievements on Its way to Become the First Fully Integrated TCR T-cell Therapy Company

Jan 8, 2018

Tricida Announces Hiring of Jeroen van Beek, Ph.D., as Chief Commercial Officer and Senior Vice President

Jan 8, 2018

Adimab Provides Year-End Update on 2017 Partnership Activities

Jan 8, 2018

Xenon Pharmaceuticals Outlines Key Milestones for 2018

Jan 6, 2018

Cleave Biosciences Promotes Kanya Rajangam to Chief Medical Officer

Jan 5, 2018

Kala Pharmaceuticals Announces Topline Results For Two Phase 3 Trials (Stride 1 And Stride 2) Of Kpi-121 0.25% In Dry Eye Disease

Jan 5, 2018

Kala Pharmaceuticals Announces New Drug Application For Inveltys™ (Kpi-121 1%) Has Been Accepted For Review By The U.S. Food And Drug Administration

Jan 4, 2018

Neurogastrx, Inc. Raises $45M Series A To Bring Lead Gi Candidate Through Proof Of Concept

Jan 4, 2018

Audentes Announces Positive Interim Data from First Dose Cohort of ASPIRO, a Phase 1/2 Clinical Trial of AT132 in Patients With X-Linked Myotubular Myopathy

Jan 4, 2018

Paul Stead Joins Adaptimmune as Vice President of Business Development

Jan 4, 2018

Rhythm Pharmaceuticals Announces Progress in Clinical Development of Setmelanotide for Treatment of Rare Genetic Disorders of Obesity

Jan 4, 2018

Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug Candidates

Jan 3, 2018

Glaukos Submits IDE Application to FDA to Study iStent infinite™ Trabecular Micro-Bypass System

Jan 3, 2018

Ascendis Pharma Announces Completion of Target Enrollment in Phase 3 Trial of TransCon Growth Hormone for Pediatric Growth Hormone Deficiency

Jan 3, 2018

ResTORbio Appoints Lynne Sullivan To Its Board Of Directors

Jan 2, 2018

SI-BONE, Inc. Announces Blue Cross Blue Shield Association Raises Clinical Evidence Rating for MIS SI Joint Fusion

Our professional values trump net present values any day. OrbiMed is a collegial culture, working together for over 25 years in a collaborative, diverse, team-oriented environment.